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Abstract
Low birth weight offspring are at increased risk for developing metabolic syndrome in later
life, specifically its precursor, insulin resistance (IR).

Reduced mitochondrial lipid

metabolism is implicated in IR pathogenesis, promoting accumulation of acylcarnitines, and
potentiating alterations in phosphorylation status of insulin signaling intermediates. While
high-energy Western diets are classically implicated in IR progression, the in utero
environment was recently highlighted as a major programming mechanism of later life IR.
Using a guinea pig model of placental insufficiency, we investigated how an adverse in utero
environment impacts later life mitochondrial lipid metabolism and IR progression, as well as
its interaction with a postnatal Western diet. Markers of mitochondrial dysfunction and
reduced lipid metabolism, including acylcarnitine accumulation, were observed in
conjunction with disrupted phosphorylation of insulin signaling intermediates in skeletal
muscle of low birth weight offspring. Additionally, a postnatal Western diet unmasked low
birth

weight-induced

mitochondrial

dysfunctions,

promoting

further

acylcarnitine

accumulation.
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Chapter 1: Introduction – Literature Review

Excerpts of this chapter have been previously published: Dunlop K, Cedrone M, Staples
JF, Regnault TR. Altered Fetal Skeletal Muscle Nutrient Metabolism Following an
Adverse In Utero Environment and the Modulation of Later Life Insulin Sensitivity.
Nutrients. 2015 Feb 12;7(2):1202-16. doi: 10.3390/nu7021202.
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1.1 Metabolic Syndrome
Throughout the world, non-communicable diseases now represent one of the
greatest strains on the global community. Furthermore, as our population ages, the
burden of treating these non-communicable diseases on the health care system continues
to increase, placing strain on the economy as well.

Non-communicable diseases,

including heart disease, stroke and diabetes are among the top six leading causes of death
in Canada, according to a 2014 survey conducted by Statistics Canada.1 Diabetes has
been shown to lead to cardiovascular diseases, including heart disease and stroke,
highlighting diabetes as a likely contributor to the development of these noncommunicable diseases.2

Of particular interest, other chronic diseases with a high

prevalence in Canada include hypertension, dyslipidemia, impaired glucose tolerance and
obesity, which together describe hallmarks of the metabolic syndrome (MetS).3

In

Canada, it was estimated that 1 in 5 individuals aged 18-79 displayed observable
manifestations of MetS between 2009 and 2011,4 a number that is only expected to
continue to increase as our population ages. Clinically, MetS is defined as a cluster of
risk factors including central obesity, hyperglycemia, dyslipidemia and hypertension,
which predispose the patient to developing cardiovascular disease, type 2 diabetes, nonalcoholic fatty liver disease, and other age-related metabolic diseases.3,5,6 The clinical
presentation of MetS remains highly contested, with various international organizations
providing different diagnostic criteria.

The World Health Organization (WHO)

guidelines for the diagnosis of MetS include the following parameters: waist
circumference greater than 102cm in men and greater than 88cm in women; fasting
glucose levels greater than 110 mg/dL; blood pressure of 140/90 mmHg or greater;
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triglyceride levels of 150 mg/dL; HDL cholesterol levels less than 35 mg/dL in men and
less than 39 mg/dL.7 However, before these overt features of MetS present, peripheral
insulin resistance often manifests, representing a key early feature of disease
progression.8,9
Of growing concern is the rapidly increasing incidence of not only MetS, but also
insulin resistance and type 2 diabetes. As of 2008/2009 approximately 1 in 11 Canadians
were living with insulin resistance or diabetes.2 The emergence of insulin resistance has
recently been highlighted as a critical pathophysiological event underlying the
development of components of MetS, disrupting the metabolic capacity of the patient and
perpetuating the development of further metabolic disease.8 Additionally, a particularly
concerning trend is the growing incidence of insulin resistance and type 2 diabetes in the
adolescent population. In the past two decades alone, the incidence of type 2 diabetes in
the adolescent population has increased worldwide,10 highlighting that research needs to
be conducted not only to determine effective treatments for management of insulin
resistance and MetS, but also for early, more effective prevention strategies targeting
youth.

1.2 Low Birth Weight (LBW) and Intrauterine Growth Restriction (IUGR)
As part of our investigation into the pathogenesis of MetS, we will be focusing on
the LBW population, as epidemiological studies have highlighted an association between
LBW secondary to IUGR and increased risk of MetS development in later life.11-13 LBW
is classically defined as an infant born with a weight less than 2500g or below the 10th
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percentile for gestational age.14 However, these arbitrary cutoffs do not account for the
fact that some babies outside these cutoffs may have been exposed to an adverse in utero
environment and grown inappropriately for their genetic potential.15-19 While these
infants are not usually classified as LBW according to the clinical definitions, they may
still have experienced metabolic adaptions to a suboptimal in utero environment that
increases their risk of later life metabolic disease, highlighting that a continuum of risk
exists among a range of birth weights.20,21
The prevalence of LBW in Canada has been holding steady at approximately 6%
between 2000 and 2007.22 However, worldwide a modest increase in the percentage of
births classified LBW has been observed over the past decade.22 LBW infants are often
considered to be “small for gestational age” (SGA), a clinical definition applied when the
infant is born with a weight below the 10th percentile for gestational age.23 However,
current growth charts often used to classify these SGA infants do not take important
factors such as race and ethnicity into account, highlighting the need for personalized
growth curves depending on sex, ethnicity and other factors that may impact growth
potential of the fetus in order to accurately represent the LBW population.24-26 The LBW
population is particularly important, since recent evidence suggests these infants are at
greater risk for perinatal mortality and morbidity, as well as long-term metabolic
disease.13,27,28
A particular cause of LBW is the suitability of the in utero environment. An
adverse in utero environment, often characterized by suboptimal nutrient transfer to the
fetus, culminates in IUGR. IUGR is a major obstetrical concern, and is the endpoint of a
continuum of conditions that result in the failure of the fetus to attain its inherent growth
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potential, leading to a low weight at birth.29 The etiology of IUGR is multifactorial, with
adverse environmental or genetic and epigenetic factors likely playing a role in the
abnormal growth and development of the fetus. One of the most important environmental
factors regulating fetal growth is nutrient delivery to the fetus which occurs via placental
diffusion and transport.30 In developed countries, a main cause of IUGR is placental
insufficiency, ultimately affecting 5-10% of all pregnancies.23 Placental insufficiency is
characterized by a reduced functional capacity of the placenta, and is typically associated
with poor placental vascular development, which prevents adequate nutrition and oxygen
from reaching the developing fetus, resulting in a hypoxic, nutrient deprived in utero
environment.31,32 Placental insufficiency may develop due to maternal vascular disease,
pre-eclampsia, placenta praevia or other placental anomalies that prevent proper
development and/or vascularization of the placenta.30 Interestingly, it should be noted
that independent of reductions in nutrient supply, hypoxia alone has been shown to have
a significant impact on fetal growth, emphasizing hypoxia as a key contributor to
impaired fetal growth and potentially IUGR.32
With exposure to a hypoxic in utero environment, the fetus undergoes key
adaptations to ensure survival. A critical component of this adaptation in the acute setting
has been considered a redistribution of fetal cardiac output towards essential organs such
as the brain, heart and adrenal glands, at the expense of other organ systems, including
the lungs, kidney, liver and skeletal muscle.33-35 With prolonged hypoxia, animal and
human studies have highlighted a redistribution of blood flow toward the brain, as well as
increased blood flow towards adrenal glands,36-39 and it is inferred from this
redistribution that the brain continues to receive sufficient perfusion and nutrient supply
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to maintain relative growth. This brain sparing effect is visible at birth, with the size of
the fetal head being larger than that of the abdomen, giving rise to an observable
asymmetrical growth restriction. Concurrent with the overall reduction in body weight
and brain sparing effect, fetuses exposed to hypoxic in utero environments also display a
reduced muscle mass compared with normal birth weight offspring,40,41 and are
predisposed to altered insulin sensitivity.8,12,13,42 Furthermore, rodent models of low birth
weight have also demonstrated a decrease in skeletal muscle mass at birth and throughout
life,43 similar to the altered muscle to fat ratio observed in older men who were LBW at
birth.44 With this altered body composition there are also metabolic changes to the
offspring, resulting in what has been proposed as a “thrifty phenotype”.12,13 This “thrifty
phenotype” encompasses a collection of metabolic adaptations initiated to aid in fetal
survival when challenged with nutrient deprivation in utero.45

1.3 The “Thrifty Phenotype” Hypothesis and The Developmental Origins of Health
and Disease
The “thrifty phenotype” hypothesis was first put forth by Forshdahl, Barker and
Colleagues in order to explain the risks associated with metabolic adaptations in utero.
Over time, this hypothesis came to be known as the “Forsdahl-Barker hypothesis”, then
later as the Developmental Origins of Health and Disease hypothesis, as further evidence
strengthening the association between growth in utero and later life disease risk was
discovered.
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The first associations between growth in utero and later life disease presentation
were observed by conducting geographical studies of lifestyle factors and cardiovascular
disease risk in Norway and England. In the 1970s, Forsdahl used official statistical data
in Norway to report a greater risk of coronary heart disease in adulthood when
adolescents were exposed to poor living conditions in early life.46,47 In the 1980s, Barker
and colleagues highlighted the emergence of paradoxical patterns whereby cardiovascular
disease rates were twice as high in poorer socioeconomic areas of Britain, highlighting
that adult lifestyle had a limited ability to predict cardiovascular disease risk.48 Further
investigation into these paradoxical patterns revealed a parallel between coronary heart
disease prevalence and death rate among newborns, providing the first clue that
cardiovascular disease risk may be linked to fetal growth.49 These geographical studies
provided the evidence required for Barker and colleagues to develop the hypothesis that
poor nutrition in utero and during early infancy had the ability to induce coronary heart
disease and an increased risk of stroke in adult life.48-51 While no biological mechanisms
were put forth by Forsdahl or Barker at this time, Forsdahl’s observation that poverty
during adolescence followed by a period of prosperity allowed for speculation that a form
of permanent damage could be caused by early nutritional deficits that is maladaptive
when exposed to later-life nutrient excess.47
Over time, further epidemiological studies have been conducted, highlighting
associations between growth in utero and later life insulin resistance and obesity,12,52 both
of which are important risk factors for development of MetS. Examination of the birth
records compiled by midwives in Hertfordshire from 1911 onwards allowed for
associations to be made within this population who still resided in the area 50-70 years
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later. Studies conducted in this population highlighted impaired glucose tolerance in
LBW men at an average age of 64, as well as presence of dyslipidemia and other
components of MetS.12 Epidemiological studies conducted in Helsinki, Finland also
highlighted a striking association between thinness at birth as a marker of suboptimal
growth in utero and body weight in adolescence. Children who were light and thin at
birth, but who were caught-up in weight by adolescence so they had an average or above
average body mass index had the highest incidence of cardiovascular disease,
highlighting rapid postnatal growth as another important contributor to later life disease
risk.53,54
Once this striking epidemiological data was presented to the scientific
community, research has continued with animal models in order to better understand the
molecular mechanisms associated with these observations. With the expansion of this
field of research, the “thrifty phenotype” hypothesis was expanded into the
Developmental Origins of Health and Disease Hypothesis in order to encompass the vast
importance of early life environment and its implications for later life disease risk (Figure
1.1).55
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Figure 1.1: Factors That May Contribute to Low Birth Weight and The
Developmental Origins of Health and Disease. An in utero insult, or collection of
insults, generally results in intrauterine growth restriction, impaired fetal growth and
development, and a low birth weight outcome. This predisposes the infant to a higher
risk of developing metabolic diseases as they age and interact with their postnatal
environment, experiencing rapid postnatal catch-up growth that may exacerbate the
effects of programmed metabolic disease.
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While the “thrifty phenotype” continues to represent the observable phenotype
associated with IUGR, theories of an accompanying altered metabolic phenotype are now
emerging. Fetal programming and developmental plasticity theories have developed,
postulating that altered oxygen and nutrient transfer during critical windows of
development, when the fetus is most sensitive to its environment, are associated with
permanent alterations in structure and metabolism, and a fixed functional capacity of vital
organs in postnatal life.13 In humans, organogenesis occurs predominantly in utero, and is
associated with a high degree of organ plasticity in order to promote metabolic
development.56 However, plasticity of the organs is decreased in postnatal life; therefore,
adaptations to these metabolic organs initiated in utero in order to aid in fetal survival
may persist into adulthood, increasing the propensity for these offspring to develop
metabolic disease as they interact with their postnatal environment.13,57
Markers of altered fetal growth, including low weight at birth and asymmetric
growth, are most widely used as indicators of IUGR or a hypoxic in utero environment.
However, more subtle adaptations at the physiological level may be the drivers
underlying the observable later life phenotypes, such as changes in skeletal muscle
metabolic function. Once the organs have fully developed in utero, the IUGR fetus faced
with a postnatal environment characterized by nutrient excess may develop long-term
adverse metabolic consequences.8,12,13 Unfortunately, the mechanisms underlying these
alterations in the metabolic capacity of the IUGR fetus and their propensity towards the
development of later life insulin resistance and MetS remain poorly defined.
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1.4 Skeletal Muscle Insulin Resistance
Skeletal muscle is the primary location for insulin-stimulated glucose uptake,
accounting for up to 70% of whole body glucose disposal,58 and is a key regulator of
whole body energy metabolism,59 with other metabolic organs, including liver, adipose
tissue and pancreas also involved in the insulin response and pathogenesis of insulin
resistance. The primary metabolic objective in the skeletal muscle is production of
adenosine triphosphate (ATP) for contractile purposes; however, skeletal muscle is also
responsible for the production and storage of glycogen, an insulin dependent process that
provides the cells with glucose for ATP production when circulating levels are low. βoxidation, a process whereby free fatty acids are broken down to provide muscle with
carbon chain substrates, is also important for skeletal muscle ATP production. Since the
skeletal muscle is a critical producer of ATP and an important location for glucose and
fat metabolism, determining the propensity of skeletal muscle towards developing insulin
resistance is a key determinant in the pathophysiological progression towards metabolic
syndrome.
Depressed insulin sensitivity, or insulin resistance, is a metabolic state in which
peripheral tissues, such as skeletal muscle, are no longer responsive to the anabolic
effects of insulin, thereby displaying reduced insulin-stimulated glucose uptake and
perpetuating a state of hyperglycemia.60 Insulin resistance at the level of the skeletal
muscle has been associated with a modulation of the serine/threonine phosphorylation
status of insulin receptor substrates (IRS).61-63 A relative increase in the serine
phosphorylation of IRS-1, the predominant isoform in skeletal muscle,64 at Ser307 reduces
its ability to activate or complex with phosphatidylinositol 3-kinase (PI3-kinase). This
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activation failure impairs downstream phosphorylation of protein kinase B (Akt) at Ser473
and Thr308, and Akt Substrate of 160 kDa (AS160) at Thr642, ultimately leading to a
reduction in glucose uptake into skeletal muscle cells through glucose transporter 4
(GLUT4) transporters (Figure 1.2).61,63,65

Figure 1.2: Molecular Manifestations of Insulin Resistance. Modulations of the
phosphorylation status, including increased inhibitory phosphorylation or decreased
activating phosphorylation, impair the ability of GLUT4 to translocate to the plasma
membrane, preventing adequate glucose uptake and perpetuating hyperglycemia.
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1.4.1 Skeletal Muscle Insulin Resistance in IUGR Offspring
A hypoxic in utero environment, commonly associated with IUGR, is known to
negatively influence the fetus during critical periods of development.8,12,13 Interestingly,
IUGR offspring in animal models display improved insulin sensitivity in very early
postnatal life, as assessed by intravenous glucose tolerance challenge; however, a shift
towards impaired glucose clearance and decreased insulin sensitivity is evident as these
offspring age.66-68 The timing of this shift in insulin sensitivity appears to be sex-specific,
with insulin action being impaired earlier in males and later in females.66 These animal
studies highlight that sexually dimorphic effects occur with adverse in utero
environments, and in the case of insulin resistance, studies suggest males appear to be
more susceptible to a programmed later life insulin resistance.66,69
Interestingly however, this sex-specific programming of insulin resistance may
not exist in humans. In a mixed cohort of offspring aged 25 who were growth restricted
in utero, a significantly lower insulin-stimulated glucose uptake was observed compared
to controls, as well as a higher plasma insulin concentration, suggesting the development
of insulin resistance irrespective of sex. Of note, these observations were in conjunction
with a normal glucose tolerance challenge, thus representing an early phase in the
pathogenesis to insulin resistance and MetS.70 However, by age 64, men who were born
small exhibited a strong link with impaired glucose tolerance and type 2 diabetes,52 while
data concerning women born small is not widely available. Therefore, understanding the
early steps in the progression towards insulin resistance in the LBW population, and any
sex-specific effects, is of critical importance for mitigating the risk of these offspring to
the development of later life type 2 diabetes.

14

Animal models of IUGR, as well as human studies, have been used in order to
identify the molecular changes occurring at the level of the insulin-signaling cascade that
may be underlying the reduced insulin sensitivity in this population.65,71 In early postnatal
life, expression of the insulin receptor is increased in LBW sheep, as a compensatory
mechanism for the low insulin and glucose levels experienced in utero.72 However, by
young adulthood skeletal muscle expression levels of the insulin receptor in LBW
offspring are no different to normal birth weight controls, highlighting that the later life
alterations in insulin sensitivity are likely due to a defect down-stream of the receptor that
affects the ability of GLUT4 to translocate to the membrane and take glucose into the
cell.71 Analysis of key intermediates in the insulin signaling cascade has demonstrated
sex-specific alterations in animal models of IUGR that may be responsible for altered
GLUT4 expression and reduced glucose uptake that is associated with states of insulin
resistance.41,65,71,73
In rodent models of placental insufficiency, young adolescent male offspring
show altered GLUT4 transport in conjunction with an increased phosphorylation of IRS1,65 which is known to blunt the physiological response to insulin63 by reducing the
coupling efficiency of the insulin receptor and IRS-1.74 IRS-1 is also known to complex
with PI3-kinase, and in young male LBW offspring, reduced expression of the p85
regulatory subunit and p110β catalytic subunit of PI3K has also been observed in rodent,
as well as larger animal (e.g., sheep) models of placental insufficiency.67,71,72
Downstream of IRS-1, the total Akt levels were not altered by insulin infusion in growth
restricted males;65,71 however, phosphorylation of this intermediate was increased by
insulin, suggesting a compensatory mechanism may be at play to maintain this
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physiological response to exogenous insulin.65 Although Akt’s involvement in the insulin
cascade appears to be unaffected, downstream AS160 shows reduced phosphorylation in
response to insulin,65 suggesting a functional impairment that impacts GLUT4
translocation to the plasma membrane.75
Human data has suggested similar molecular alterations are present in young
LBW males, including reduced expression of the p85 and p110β subunits of PI3-kinase
and reduced skeletal muscle GLUT4 content.40,71 These alterations occur in conjunction
with a blunted phosphorylation of Akt in response to insulin infusion, but with
maintenance of glucose tolerance and whole body insulin sensitivity.40,71 Taken together,
changes in the molecular expression of key insulin signaling intermediates in skeletal
muscle of LBW offspring may precede development of whole body insulin resistance and
glucose intolerance, representing an early defect in metabolism, or pre-diabetic state, that
could be indicative of future metabolic disease.71 However, the mechanisms by which the
in utero environment may be modulating these changes in insulin sensitivity remain ill
defined.

1.5 Origins of Skeletal Muscle Insulin Resistance
Traditional factors identified in the development of insulin resistance have been
poor diet and sedentary lifestyle. The increasing prevalence of a “Western”, or energydense, high-fat/high-sugar diet, has been implicated as a key factor contributing to the
pathogenesis of insulin resistance, promoting accumulation of fat within the skeletal
muscle associated with a state of lipid overload and impacting mitochondrial function,76-
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leading to a diminished capacity for mitochondrial fatty acid oxidation associated with

mitochondrial dysfunction.79

1.5.1 Lipid Overload
Consumption of this energy-dense diet generates a surplus of free fatty acids,
ultimately leading to ectopic lipid accumulation in non-adipose tissues such as skeletal
muscle.80 Once in the skeletal muscle, excess fatty acids are activated to form their acylCoA derivatives, which can be esterified into diacylglycerol (DAG), metabolized into
ceramide, or conjugated to acylcarnitine for entry into the mitochondria to undergo βoxidation.81 Excess lipids may also be stored in lipid droplets as triacylglycerols,
generating a pool of substrates termed intramyocellular triglycerides (IMTG).77 IMTG
content is known to increase with percentage body fat, and to be elevated in obese or type
2 diabetic individuals.82 IMTGs are broken down by lipases to undergo oxidation;
however, disturbances in the rate of breakdown or oxidation may lead to accumulation of
toxic lipid intermediates and subsequent insulin resistance.77,83 The type of triglyceride
(saturated vs. unsaturated) that make up the skeletal muscle lipid pool is also important,
since unsaturated triglycerides may be destined to accumulate as IMTG, whereas
saturated triglycerides may be broken down into DAGs.84 Additionally, a higher
proportion of saturated fatty acids within this lipid pool has recently been associated with
insulin resistance.84
In rodent lipid infusion studies, insulin resistance develops secondary to increased
concentrations of long-chain acyl-CoAs in the skeletal muscle.61 This increased lipid
availability has been associated with reduced levels of skeletal muscle β-oxidation,85,86
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leading to accumulation of toxic lipid metabolites including DAG61 and ceramide.87
While specific changes in long-chain acyl-CoA levels have not been reported in IUGR or
LBW offspring, reductions in enzymes involved in β-oxidation have been reported,88
suggesting that accumulation of long-chain acyl-CoAs secondary to a reduction in
oxidative capacity may be involved in the pathogenesis of insulin resistance.
Accumulation of these lipid metabolites in the skeletal muscle has been associated
with increases in stress-induced kinases, such as protein kinase C (PKC)-θ or ε, isoforms
known to act upstream of c-Jun N-terminal kinase (JNK) and IκB (inhibitor of NFκB)
kinase (IKKβ). Notably, JNK and IKKβ are two central serine/threonine kinases
mediating phosphorylation of IRS-1 at Ser307. Increased inhibitory serine phosphorylation
of IRS-1 induces a subsequent reduction in Ser473 phosphorylation of Akt, and reduced
insulin-stimulated glucose uptake,61,81,87,89 similar to the molecular alterations that have
been observed in the insulin signaling pathway in skeletal muscle of the LBW
population.65,71 PKC-θ activation itself (translocation from the cytosol to the plasma
membrane) has also been reported to occur during a state of lipid overload in skeletal
muscle, and may represent an alternative pathway mediating alterations in the
serine/threonine phosphorylation status of key insulin signaling intermediates.61,83 Direct
evidence that these changes may be happening in LBW, IUGR offspring as they age is
still lacking, but if occurring, presents a potential pathway where in utero induced
changes in skeletal muscle metabolic capacity may play a contributing role to later life
insulin resistance when challenged with a postnatal high fat diet.
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1.5.2 Mitochondrial Dysfunction
Recently, reports implicating mitochondrial lipid metabolism in the pathogenesis
of insulin resistance have emerged in addition to the traditional lipid overload theories
described above. Skeletal muscle relies heavily on fatty acid β-oxidation to generate
energy, using this method to provide up to 90% of its total energy demand.79 Therefore,
any alterations in fatty acid oxidation may impair skeletal muscle oxidative capacity.
Certainly in rodent IUGR studies, muscle oxidative capacity is adversely affected in
growth-restricted animals, preventing ATP generation,43,90 and as such could set the stage
for impaired mitochondrial function when challenged with a postnatal Western diet.
Mitochondrial metabolism represents a complex series of enzymatic events
initiated to oxidize lipids to carbon dioxide, with the ultimate goal of producing energy in
the form of ATP. A definition of mitochondrial dysfunction has recently been proposed
that implicates decreased mitochondrial oxidation of substrates resulting from a global
reduction in oxidative phosphorylation.91 This decreased oxidation characteristic of
mitochondrial dysfunction may be induced due to decreased protein content or activity of
oxidative proteins and/or reduced mitochondrial biogenesis or content.91 Mitochondrial
dysfunction has also been associated with accumulation of toxic lipid intermediates as
described above, as well as accumulation of acylcarnitine intermediates, in association
with alterations in insulin signaling.92

However, the exact mechanisms linking

mitochondrial dysfunction and insulin signaling remain complex and poorly understood.
In order to fully comprehend the scope of mitochondrial dysfunction and its role
in the pathogenesis of insulin resistance, knowledge of normal mitochondrial lipid
metabolism is essential. The process begins with long-chain fatty acid generation from
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lipolysis in adipose tissue, or breakdown of triglycerides in very low-density lipoproteins
or chylomicrons.93 Once these long-chain fatty acids are formed they are taken up into
skeletal muscle either through passive diffusion, or the coordinated actions of fatty acid
translocase/cluster of differentiation 36 (FAT/CD36) and the family of fatty acid
transport proteins (namely FATP1 and 4).93 While the majority of fatty acid chains will
be oxidized in the mitochondria, a subset of very-long chain fatty acids may be
preferentially diverted towards the peroxisomes to undergo β-oxidation in this location,
generating the reactive oxygen species hydrogen peroxide as a signaling intermediate.94
To initiate the oxidative process in the mitochondria, fatty acyl-CoAs must enter
the mitochondrial matrix through the carnitine palmitoyltransferase (CPT) system.95 This
system consists of subcellular CPT1, which exchanges the Co-A moiety of the fatty acid
for carnitine, forming an acylcarnitine. Once the acylcarnitine has crossed into the
mitochondria through acylcarnitine translocase, it is converted once again to its acyl-CoA
form by CPT2, in order to continue through the oxidative process.95 It is important to
note that CPT1 is allosterically regulated by malonyl-CoA, an intermediate derived from
glucose metabolism and the first step of lipogenesis, thus providing an important control
mechanism for regulating oxidative rate, making CPT1 the control point, or rate-limiting
enzyme of mitochondrial oxidation.93
Now that the fatty acyl-CoAs have been transported into the mitochondria, they
undergo a series of enzymatic reactions collectively termed β-oxidation. This process
begins when acyl-CoA dehydrogenase enzymes selectively oxidize the acyl group of the
fatty acid depending on the length of the chain. For example, very-long chain acyl-CoA
dehydrogenase (VLCAD) acts on fatty acid chains greater than 22 carbons long, whereas
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medium chain acyl-CoA dehydrogenase acts on fatty acids with a chain length between 6
and 12 carbons.96

Following dehydrogenation, the carbon chain then undergoes

hydration and another oxidation step, followed by thiolysis catalyzed by 3-ketoacyl CoA
thiolase (KT), ultimately releasing acetyl-CoA.96 This 4-step cycle continues, generating
2 carbon acetyl-CoA molecules at each iteration, until the entire long-chain has been
reduced to an acetyl-CoA intermediate. These acetyl-CoA intermediates generated from
β-oxidation are then fed into the tricarboxylic acid (TCA) cycle, a series of enzymatically
driven reactions that generate carbon dioxide and the electron carriers, nicotinamide
adenine dinucleotide (NADH) and flavin adenine dinucleotide (FADH2).97 NADH and
FADH2 then enter the electron transport chain, where the energy from the electrons
carried on these intermediates is harnessed to pump protons across the mitochondrial
membrane to generate the electrochemical gradient required for ATP synthesis through
the process of oxidative phosphorylation (Figure 1.3).95,97
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Figure 1.3: Mitochondrial Lipid Oxidation Pathway. Fatty acids enter the cell via fatty
acid transporters, and are then transported into the mitochondria through the co-ordinated
actions of CPT1 and CPT2. Once in the mitochondria, the fatty acyl-CoA undergoes βoxidation, successively reducing the fatty acid chain by 2 carbons and generating acetylCoA intermediates for use in the TCA Cycle. The TCA cycle then generates CO2 and the
reducing co-factors NADH and FADH2, which are fed through the complexes of the
electron transport chain, with the ultimate goal of generating energy in the form of ATP.
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Defects along this oxidative pathway have the potential to allow for accumulation
of acylcarnitine metabolites, which have recently emerged as strong indicators of
mitochondrial dysfunction and increased nutrient load.62,98 Acylcarnitine accumulation in
tissue is indicative of impairment in the utilization of the substrates generated through βoxidation for downstream energy production, and the presence of fatty acids that are
incompletely oxidized.99 The recent interest in the field of metabolomics, which uses
mass spectrometry techniques to determine how metabolic intermediates are altered in
disease states, has allowed for profiling of these acylcarnitine intermediates. The surge in
metabolomics research has highlighted a method well suited to further investigation of
the relationship between mitochondrial dysfunction, incomplete β-oxidation and the
pathogenesis of insulin resistance. For example, high-fat feeding in rodents has been
shown to induce a lipid profile high in even-chain acylcarnitines. Accumulation of these
even-chain acylcarnitine species ranging in length from 6 carbon chains (C6) to 22
carbon chains (C22) indicates that a large proportion of the fatty acids entering the
mitochondria are only partially degraded for use as metabolic substrates.62,100 Of interest,
recent evidence has suggested that one even-chain acylcarnitine in particular, C14
carnitine, which can accumulate in situations of incomplete β-oxidation, has the ability to
activate pro-inflammatory pathways, as well as an induction of JNK which may modulate
the serine/threonine phosphorylation status of insulin signaling intermediates,
perpetuating a state of insulin resistance.89,101 Mitochondrial dysfunction has also been
observed in rodent models of diabetes, including the Zucker Diabetic Fatty rat, further
supporting the idea that incomplete fatty acid oxidation and accumulation of acylcarnitine
intermediates may be implicated in the pathogenesis of insulin resistance.62,102 Currently,
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the impact of high fat feeding in LBW, IUGR offspring upon acylcarnitine production
and mitochondrial dysfunction has not been reported. However, short-term high fat
feeding trials in human LBW offspring show that LBW is associated with a reduced
degree of metabolic plasticity,103 suggesting that in utero-induced changes to
mitochondrial oxidation may be unique in LBW offspring. Given the impact of diet
alone upon acylcarnitine accumulation, a LBW situation in conjunction with poor
postnatal diet may potentially exacerbate acylcarnitine accumulation and mitochondrial
dysfunction.

1.5.3 Regulation of Mitochondrial Function and Biogenesis
The regulation of mitochondrial biogenesis and respiration is an important
element determining oxidative capacity and the subsequent propensity for development
of insulin resistance. The genes and enzymes involved in the oxidative process must be
tightly regulated in order to adequately oxidize incoming fatty acids, generating cofactors and TCA substrates to generate ATP for cellular demand. This is accomplished
by a tight co-ordination and interactions between a number of transcription factors
regulating the enzymes involved in mitochondrial β-oxidation, including peroxisome
proliferator-activated receptors, their co-activators, sirtuins, and the forkhead/winged
helix transcription factors that each mediate an important aspect of mitochondrial
biogenesis and oxidative function.
One such regulator of lipid oxidation is peroxisome proliferator-activated receptor
alpha (PPARα), which is mainly expressed in tissues with a high oxidative capacity such
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as the liver, heart, and skeletal muscle.79 PPARα is activated upon binding of neutral
lipids, promoting fatty acid uptake, and is involved in the induction of oxidative target
genes with a PPARα response element, including CD36, CPT1b, VLCAD, MCAD and
KT.100,102,104,105 As such, increased activity of PPARα promotes mitochondrial βoxidation. However, in order for full activation of PPARα and induction of its gene
targets, co-ordination with peroxisome proliferator-activated receptor-gamma coactivator 1-alpha (PGC-1α) is required as a critical component of the PPARα-activated
transcriptional machinery.100 High levels of PGC-1α activity not only activate genes
related to β-oxidation through the actions of PPARα, but also activate genes involved in
the

TCA

cycle,

including

α-ketoglutarate

dehydrogenase

and

succinate

dehydrogenase.105,106 Additionally, PGC-1α in complex with nuclear respiratory factor-1
(NRF-1) has the ability to induce transcription of components of oxidative
phosphorylation, including subunits of complexes I through V.106 Furthermore, this
highlights PGC-1α as a key regulator of optimal mitochondrial function that promotes the
complete oxidation of fatty acids.105

Loss of PGC-1α has been implicated in the

pathogenesis of insulin resistance in the context of high-fat diets, such that consumption
of a high-fat diet decreases muscle PGC-1α expression, leading to a reduction in the
coupling efficiency between β-oxidation and the TCA cycle, and coinciding with a shift
from complete to incomplete β-oxidation, accumulation of acylcarnitines and altered
insulin sensitivity.100,105 Recent studies have also reported reduced levels of PGC-1α
mRNA107,108 and protein in the soleus108 and gastrocnemius109 muscles of young
adolescent LBW offspring, as well as alterations in the methylation status of the PGC-1α
promoter of both rodent109 and human110 models of IUGR. However, expression levels of
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mitochondrial regulators of β-oxidation following consumption of a high-fat diet,
combined with a LBW situation remain to be fully elucidated.
Another important family of transcription factors involved in the regulation of
mitochondrial biogenesis as it relates to oxidative capacity is the sirtuins (SIRTs). SIRTs
are responsible for cellular energy sensing, as they are modulated by the availability of
metabolic cofactors, including NAD+ and NADH, therefore acting as a regulatory
mechanism for the mitochondrial oxidative process in response to nutrient availability.111
Seven SIRT isoforms have been identified in mammals; however, in terms of the
regulation of overall mitochondrial function, the most notable isoforms are SIRT1 and
SIRT3.112 SIRT1 is predominantly localized to the nucleus, as well as the cytosol and
mitochondria,113 where it deacetylates target proteins involved in lipid metabolism and
energy balance.111 SIRT1 is activated during situations in which cellular energy is low
(high NAD+/NADH ratio) in order to induce fatty acid oxidation by deacetylating PGC1α and PPARα, allowing a global induction of oxidative genes with the ultimate goal of
increasing ATP production.105,111,113 On the other hand, SIRT3 is localized exclusively to
the mitochondria and may have the potential to deacetylate proteins involved in the
electron transport chain, highlighting SIRT3 as an important regulator of ATP synthesis
and mitochondrial energy metabolism.114,115 Recent reports suggest SIRT3 may also
regulate metabolism at the oxidative level by initiating deacetylation of long-chain acylCoA dehydrogenase (LCAD) in order to promote β-oxidation.116

Therefore,

dysregulation of mitochondrial biogenesis or oxidative function due to decreased
availability or activity of the above-mentioned factors, including PPARα, PGC-1α,
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SIRT1 and/or SIRT3, has the potential to promote mitochondrial dysfunction and reduced
lipid oxidation (Figure 1.4).

Figure 1.4: Regulation of Mitochondrial Lipid Oxidation. In order for lipids to be
completely oxidized, tight co-ordination between a number of transcription factors is
required. In resting states, PGC-1α and PPARα are acetylated, preventing their coordination. To induce the gene targets involved in β-oxidation and increase the oxidation
rate, deacetylation by SIRT1 is required to allow PGC-1α and PPARα to complex
together. PGC-1α on its own, in its deacetylated state, is also able to induce genes
involved in the TCA cycle and electron transport chain, promoting complete lipid
oxidation. SIRT3, which resides exclusively in the mitochondria, is responsible for
deacetylating protein targets in the electron transport chain, in order to maintain its
activity and promote ATP generation.
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Unfortunately, the link between mitochondrial dysfunction and insulin resistance
remains unclear. Is mitochondrial dysfunction the insult that induces insulin resistance,
or does a primary insult of insulin resistance promote mitochondrial dysfunction? While
this relationship remains complex and elusive, important insight into how insulin
signaling and mitochondrial metabolic pathways intersect has been brought forth in
recent years. One important transcription factor in this relationship between insulin
signaling and mitochondrial metabolism has been identified, namely the forkhead/winged
helix transcription factor FOXO1.92 FOXO1 is important in regulating cell proliferation,
as well as mediating the expression of hundreds of genes involved in gluconeogenesis,
lipid metabolism and oxidative stress.117 Recently, FOXO1 has been identified as a
substrate

of

Akt,

containing

three

phosphorylation

sites

for

Akt-mediated

phosphorylation (Thr24, Ser256, Ser319).118 Phosphorylation of these residues, secondary to
Akt activation through the insulin signaling cascade, promotes FOXO1 nuclear exclusion
and translocation to the cytosol, inhibiting FOXO1-mediated gene expression and
regulating rates of gluconeogenesis and lipid metabolism in response to nutrient
availability.119

In situations of insulin resistance, impairment of IRS and reduced

activation of Akt allows for hyperactivation of FOXO1, which has the ability to disrupt
the electron transport chain by inducing expression of heme oxygenase 1 (HMOX1)
which depletes heme availability, an essential cofactor facilitating electron transport.92 By
disrupting mitochondrial oxidative phosphorylation, the NAD+/NADH ratio decreases,
blunting the activation of SIRT1 and PGC-1α-mediated mitochondrial biogenesis and
impairing fatty acid oxidation, promoting a state of mitochondrial dysfunction.92
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However, whether insulin resistance is the result of accumulation of intermediates
associated with mitochondrial dysfunction remains unclear.

1.6 Rationale, Hypothesis, Objectives
1.6.1 Rationale and Hypothesis
Recent evidence has suggested that infants of an adverse in utero environment
represent a unique population who appear to be at greater risk for development of insulin
resistance and other components of MetS.12,13,49-52 Adaptive, programmed changes in
metabolic development and function initiated to aid in fetal survival are thought to lead to
structural and metabolic deficits in later life.8

However, the molecular alterations

associated with these programmed changes and their role in promoting later life
metabolic disease remain unclear. While defects in the skeletal muscle metabolism of
LBW offspring have been highlighted in both human and animal studies, including
alterations in insulin sensitivity and oxidative phosphorylation,40,43,71,120 the in utero
contributors to the origins of insulin resistance and the relative contribution of in uteroinduced alterations to skeletal muscle fatty acid metabolism and mitochondrial function
on the progression of insulin resistance remain ill defined.
Further, and more concerning, are recent studies suggesting that these LBW
offspring are unable to lose weight as efficiently as normal birth weight offspring when
maintained on a 40%-calorie restricted diet,43 and that PGC-1α deficiencies associated
with IUGR appear resistant to exercise intervention.121 These studies highlight that these
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offspring, while being at a higher risk of developing aspects of metabolic disease, may be
resistant to current intervention practices.

Additionally, when these infants with

programmed alterations in skeletal muscle development are faced with a postnatal
environment of nutrient excess, they appear to be at greater risk for aberrant skeletal
muscle function.8,13 Therefore, understanding the unique relationships and subtle
metabolic differences between low and normal birth weight infants and how they interact
with their postnatal nutritional environment is an important step in determining methods
to improve skeletal muscle insulin sensitivity in order to mitigate the risk of these LBW
offspring developing MetS in later life. As such, we postulate that IUGR is associated
with in utero-induced alterations in skeletal muscle lipid oxidation, which impair
insulin sensitivity, independent of postnatal diet. Early exposure to a poor postnatal
diet may have the potential to exacerbate the already dysfunctional system, further
increasing the risk of developing insulin resistance and progression to MetS in young
adulthood.

1.6.2 Objectives
The first objective of the study is to assess growth and metabolic parameters of guinea
pig offspring of an adverse in utero environment independently, and in conjunction with
a postnatal high-fat/high-sugar diet, in order to investigate the relative contributions of
the components of the in utero environment and postnatal diet on glucose tolerance and
body composition as they relate to early markers of the pathogenesis of MetS.
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The second objective of the study is to investigate the impact of an adverse in utero
environment upon skeletal muscle lipid metabolism independently, and in conjunction
with a postnatal high-fat/high-sugar diet, focusing on mitochondrial lipid oxidation,
acylcarnitine accumulation and mitochondrial dysfunction, as a contributor to the
pathogenesis of insulin resistance.
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Chapter 2:
Growth and Body Composition of Guinea Pig Offspring are Altered in Response to
Low Birth Weight and Postnatal Exposure to a “Western” Diet

Data presented in this chapter is part of a larger work profiling our entire cohort, which is
currently in preparation for submission.
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2.1 Introduction
Metabolic syndrome (MetS) is characterized by a cluster of risk factors, including
hyperglycemia, central obesity, hypertriglyceridemia, dyslipidemia and high blood
pressure,1,2 which ultimately increases the patient’s risk of developing cardiovascular
disease, type 2 diabetes, and other age-related metabolic diseases.3 An early marker of
disease progression is insulin resistance, as it is typically observable before overt
manifestations become apparent.4

Insulin resistance is a metabolic state in which

peripheral tissues are no longer sensitive to the anabolic effects of insulin, perpetuating a
state of hyperglycemia, further validating insulin resistance as a critical precursor to the
pathophysiological development of MetS.4
The prevalence of MetS and its associated morbidities are steadily increasing in
developed countries, with recent surveys estimating that 1 in 5 Canadians aged 18-79
display observable manifestations of MetS.5 Classically, the origins of MetS and insulin
resistance have largely been attributed to lifestyle factors, including consumption of
energy-dense diets and sedentary behavior.6 The increasing prevalence of the symptoms
associated with MetS mirrors the increase in obesity rates, which is largely attributable to
increased consumption of energy-dense, high-fat/high-sugar, “Western” diets and their
propensity to induce a state of insulin resistance.6 These Western diets, with their high
percentage of saturated fatty acids and low percentage of poly-unsaturated fatty acids,7
alter lipid metabolism, induce an inflammatory state, and promote altered insulin
sensitivity, increasing the patient’s risk for developing cardio-metabolic disease.6,8 The
Western diet is also characterized by a high percentage of added sugars,9 including
fructose, which alters carbohydrate and glucose metabolism and impact insulin
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sensitivity, likely further contributing to the development of a state of insulin
resistance.10,11 These increases in fats and sugars independently, and in combination,
alter growth trajectory, favouring fat deposition and accelerating development of obesity
and metabolic disease, promoting MetS progression.
Recently, human epidemiological studies have highlighted that an adverse in
utero environment that restricts fetal growth, culminating in intrauterine growth
restriction (IUGR) and low birth weight (LBW), increases the propensity for the
offspring to develop age-related metabolic and cardiovascular diseases in later life.12
Indeed, the recent EPOCH study highlighted higher fasting insulin levels and homeostatic
model assessment of insulin resistance (HOMA-IR) values indicative of impaired insulin
sensitivity as early as 10 years of age in IUGR-exposed children, independent of both
childhood body mass index (BMI) and BMI trajectory following a period of “catch-up
growth” during the first year of life.13 Similarly, reports of a 7-fold increased risk for
development of insulin resistance by the age of young adulthood have also been
observed.14 Furthermore, this pattern holds throughout the life-span, with low birth
weight males at age 64 exhibiting a strong association with impaired glucose tolerance, a
marker of whole-body insulin resistance and type 2 diabetes.15 Additionally, animal
models of low birth weight generated through a variety of means, including caloric
restriction, maternal protein restriction and uterine artery ligation, have confirmed the
impact of an adverse in utero environment on an increased incidence of cardiovascular
disease, visceral obesity and hypercholesterolemia in these offspring.4,16-20 Overall, these
human and animal studies highlight that metabolic adaptations to an adverse in utero
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environment are associated with a predisposition for development of aspects of MetS in
later life.
The Developmental Origins of Health and Disease (DOHaD) hypothesis has
developed immensely over the last thirty years to postulate how adaptations to limited
nutrient and oxygen supply, as a consequence of reduced placental blood flow to the
fetus, results in an adverse in utero environment which would have the ability to
permanently program structural and functional alterations to major metabolic organs.4
These adaptive responses during critical periods of in utero development are thought to
program a “thrifty phenotype” which aids in immediate survival of the fetus. One overt
manifestation of this adaptive growth in utero is a leaner phenotype at birth as a
consequence of reduced muscle mass,21,22 which has been associated with a programmed
predisposition to altered insulin sensitivity in later life.4,12,14,20

Since organogenesis

occurs predominantly in utero and is followed by a period of rapid fetal growth and loss
of organ plasticity shortly after birth,23,24 environmental insults during this sensitive
period of development have the potential to result in a fixed functional capacity of vital
metabolic organs.24 As such, these adaptive responses in response to an adverse in utero
environment have the potential to induce a propensity for life-long metabolic
consequences as these offspring interact with their postnatal environment.12,20
Additionally, IUGR and LBW are associated with a period of rapid postnatal
catch-up growth which further modulates later-life disease risk.12

The cessation of

growth experienced in utero is suggested to slow the genetic growth program of the fetus,
delaying the loss of proliferative capacity typically experienced following birth, allowing
for rapid catch-up growth to occur in early life.25 However, this period of rapid growth in
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early life has been associated with increased childhood adiposity,26 as well as an
increased strain on vital metabolic organs that contribute to the development of MetS.27
In comparison to the nutrient deprivation experienced in utero, introduction to a postnatal
environment characterized by relative nutrient excess also has the potential to induce
postnatal catch-up growth and alter the metabolic capacity of vital organs, increasing the
offspring’s risk for developing metabolic disease with age.24
Recently, evidence has suggested that in utero influences and secondary insults in
adult life may have a synergistic effect, further exacerbating an already dysfunctional
system and promoting earlier onset of MetS.12 While some studies have suggested the
prevalence of childhood obesity has begun to plateau in the United States,28 it still
remains a concern worldwide. Indeed, using the WHO guidelines for classifying obesity
in children, it was estimated that approximately 33% of children in Canada aged 5 to 11
years were overweight or obese between 2009 and 2011.29 This increased incidence of
childhood obesity can largely be attributed to early introduction of energy-dense diets and
sedentary behavior;28 however genetics and the contribution of the in utero environment
cannot be negated. Ultimately, altered childhood growth and body composition, namely
obesity, have the potential to influence later-life disease risk, putting these children at
increased risk of developing symptoms associated with MetS at an earlier age.30 While
the increasing prevalence of childhood obesity and poor food choices in our society
continues to expand, the postnatal effects of consumption of an energy-dense Western
diet still remain largely unexplored in LBW offspring. As such, we sought to assess body
composition, growth parameters and glucose tolerance as a marker of the MetS
phenotype in guinea pig offspring of an adverse in utero environment. Additionally, we
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investigated body composition, growth and glucose tolerance in offspring of an adverse
in utero environment in conjunction with a postnatal high-fat/high-sugar diet in order to
investigate the relative contributions of the components of the diet on progression of the
MetS phenotype.
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2.2 Materials and Methods
2.2.1 Ethics Statement
Animal care, maintenance and surgical procedures were conducted in accordance
with the guidelines of the Canadian Council on Animal Care. All procedures were
approved by The University of Western Ontario Animal Use Subcommittee (Appendix
II).

2.2.2 Animal Handling
Time-mated pregnant Dunkin-Hartley guinea pigs (Charles River Laboratories,
Wilmington, MA, USA) were housed in a constant temperature (20°C) and humidity
(30%) controlled environment with 12h light/dark cycle. All animals had ad libitum
access to standard guinea pig chow (LabDiet diet 5025) and tap water.
All pregnant guinea pigs underwent uterine artery ablation, as previously
described,31 to induce uteroplacental insufficiency and IUGR. At mid-gestation (~32
days, term ~67 days), sows were anesthetized in an anesthetic chamber (4-5% isoflurane
with 2L/min O2, followed by 2.5-3% isoflurane with 1L/min O2 for maintenance).
Immediately following induction of anesthesia, a subcutaneous injection of Rubinol
(Glycopyrrolate, 0.01mg/kg, Sandoz Can Inc., Montreal, QC) was administered. A
midline incision was made below the umbilicus, exposing the bicornate uterus. Arterial
vessels feeding each horn of the uterus were identified, and every second branch was
cauterized using an Aaron 2250 electrosurgical generator (Bovie Medical, Clearwater,
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FL), then the abdominal cavity closed. Immediately following surgery, a subcutaneous
injection of Temgesic (Buprenorphine, 0.025mg/kg, Schering-Plough Co., Kenilworth,
NJ) was administered, and regular post-operative monitoring undertaken. Sows delivered
spontaneously at term (approximately 67-69 days),31 at which time pup weight, length,
abdominal circumference and biparietal distance were measured. At the end of the
pupping period, male guinea pigs were allocated to the low birth weight (LBW) group if
birth weight was below the 25th percentile, and the normal birth weight (NBW) group if
birth weight was between the 25th and 75th percentile (Figure 2.1). Based on these
criteria, LBW pups were below 80g, and NBW pups were above 90g, in accordance with
previously reported data.19,32
Pups remained with their dams during the 15-day lactation period. Five days
prior to weaning, all pups were introduced to small amounts of a control diet (Harlan
Laboratories TD.110240: Table 2.1) and weaned on postnatal day (PND)15 into
individual cages. At this time, guinea pig offspring were randomized to either a control
(CD, Harlan Laboratories TD.110240: Table 2.1) or a Western (WD, Harlan Laboratories
TD.110239: Table 2.1) diet. To avoid litter effects, only one male LBW and one male
NBW animal from a single litter was assigned to each diet. From the time of weaning,
feed intake was measured daily, and body weights were measured daily until PND50,
then twice weekly until PND145, corresponding to young adulthood.16,33
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Figure 2.1: Birth Weight Distribution. Pregnant sows underwent uterine artery ablation
at mid-gestation in order to induce placental insufficiency and intrauterine growth
restriction. Briefly, in anesthetized sows, a midline incision was made below the
umbilicus, exposing the bicornate uterus. Arterial vessels feeding each horn of the uterus
were identified, and every second branch was cauterized, reducing placental blood flow,
oxygen and nutrient transfer to the fetus. Following spontaneous pupping, pups born
below the 25th percentile (dashed line) were classified as low birth weight (LBW), and
those above the 25th percentile were classified as normal birth weight (NBW). Animals
between 80g and 90g (grey, hatched bar) were excluded from analyses.
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Component

Control Diet (CD)

Western Diet (WD)

Total protein (isolated soy
protein, %kcal)

22

21

Total Fat (%kcal)

18

46

Saturated Fatty Acids

15

70

Poly-unsaturated Fatty
Acids

61

4

Mono-unsaturated Fatty Acids

24

26

C12:0

1.26

17.90

Myristic Acid (C14:0)

1.28

9.33

Palmitic Acid (C16:0)

14.74

21.64

Stearic Acid (C18:0)

5.93

16.96

Oleic Acid (C18:1cis9)

25.60

26.72

Linoleic Acid (C18:2n-6)

46.04

7.45

Alpha Linoleic Acid (C18:3n-3)

5.15

-

60

33

Sucrose

11

22

Fructose

-

7.6

-

0.25

3.4

4.2

Fatty Acid Composition
(%weight)

Total Carbohydrate (%kcal)

Cholesterol (%kcal)
Density (kcal/g)

Table 2.1: Composition of the Postnatal Diets.
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2.2.3 Analysis of Growth and Feed Intake
Absolute growth rate (AGR: g/day), percent increase in body weight, and
fractional growth rate (FGR: AGR/birth weight)16 were calculated for the 15-day
lactation period for n=20 NBW and n=18 LBW offspring.
The post-weaning period was divided into three intervals: weaning-PND50
representing the period of maximal growth, PND51-110 representing the period of
adolescent growth, and PND111-145 representing the plateau period in young adulthood.
For each interval, the AGR, average food intake (g/day/kg body weight), calorie
consumption (calories/day) and efficiency (g gained/day/calories consumed/day) were
calculated for n=11 NBW/CD, n=11 LBW/CD, n=9 NBW/WD and n=7 LBW/WD
offspring.

2.2.4 Computed Tomography (CT) Measurements
At approximately PND110, in vivo computed tomography scans were performed,
as previously described,19 in order to quantify total adipose tissue, bone and muscle
volume of the whole body (from proximal tibia to base of skull).34 Briefly, anesthesia
was induced in an anesthetic chamber using 4-5% isoflurane with 2L/min O2, and
maintained with 1.5-3% isoflurane. Images were taken using a Discovery CT750 HD
scanner (GE Healthcare, Mississauga, ON) at 1.25mm slices, with voltage and current set
to 80kV and 100mA, respectively.

Using a MATLAB developed program (The

Mathworks Inc., Natick, MA), bone, muscle and adipose tissue were differentiated by
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thresholding the CT image slides of the guinea pig.35 Using pixel size and thickness of
each CT image, volumes (cm3) of bone, muscle and adipose tissue type were calculated
for each tissue type and expressed as a percentage of total body volume for n=4-5
animals per group.

2.2.5 Glucose Tolerance Testing
At PND60 and PND120, intraperitoneal glucose tolerance tests (IPGTTs) were
performed on n=12 NBW/CD, n=12 LBW/CD, n=9 NBW/WD and n=7 LBW/WD
offspring to assess whole body glucose tolerance. Following an overnight (16h) fast, a
bolus injection of 0.5% dextrose (1g/kg body weight)16,36 was administered
intraperitoneally. Blood was sampled at the peripheral ear vein at times 0, 10, 20, 50, 80,
110, 140, 170, and 200 minutes following injection. Blood glucose levels were measured
using a Bayer Contour hand-held glucometer (Bayer Diabetes, Mississauga, ON). Area
under the glucose curve was calculated using GraphPad Prism 6 (GraphPad Software,
San Diego, CA) for each animal as a measure of glucose clearance.37

2.2.6 Statistical Analyses
All data presented are mean ± standard error (SEM). Statistical significance
during the lactation period was determined using a two-tailed unpaired t-test. Two-way
ANOVA followed by post-hoc Tukey’s test was performed to assess the effects of birth
weight and postnatal diet. Two-way ANOVA Repeated Measures, followed by post-hoc
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Tukey’s test, were performed to assess the effects of birth weight and postnatal diet over
the course of the experimental period. All statistical analyses were performed using
GraphPad Prism 6 (GraphPad Software, San Diego, CA).
considered statistically significant.

Values of p<0.05 were
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2.3 Results
2.3.1 Uterine Artery Ablation Results in Growth Restriction of LBW Offspring
At the time of birth, LBW offspring displayed indications of growth restriction.
Birth weight/birth length, a measure of leanness,16 was significantly (p<0.001) reduced in
LBW offspring, compared to NBW offspring (Table 2.2).

Biparietal diameter was

significantly (p<0.05) decreased in LBW offspring, compared to their NBW counterparts
(Table 2.2). Crown-rump distance was significantly (p<0.01) reduced in LBW offspring
(Table 2.2). Abdominal circumference was reduced (p=0.0544) in LBW offspring (Table
2.2).

Biparietal
Distance
(cm)

CrownRump
Length
(cm)

Abdominal
Circumference
(cm)

Ponderal
Index
(g/cm3)

Birth
Weight/
Birth
Length
(g/cm)

Absolute
Growth
Rate
(g/day)

%Increase
in Body
Weight

Fractional
Growth
Rate

NBW

2.16 ±
0.035

15.49 ±
0.32

11.56 ± 0.17

0.029 ±
0.002

6.7 ±
0.21

9.50 ±
0.26

115.7 ±
3.79

0.092 ±
0.002

LBW

2.04 ±
0.039

13.97 ±
0.38

10.98 ± 0.24

0.029 ±
0.002

5.46 ±
0.22

8.29 ±
0.24

149.6 ±
6.14

0.113 ±
0.004

*

**

p=0.0544

ns

***

**

****

****

Table 2.2: Birth Characteristics and Lactation Period Growth.
Following
spontaneous birth, pup weights, length, biparietal distance, and abdominal circumference
were measured as indicators of growth restriction. Pup weight was measured daily
throughout the 15-day lactation period. Data presented are mean ± standard error (SEM)
for n=20 normal birth weight (NBW) and n=18 low birth weight (LBW) offspring.
Statistical significance was determined by two-tailed unpaired Student’s t-test. *p<0.05,
**p<0.01, ***p<0.001, ****p<0.0001, ns = not significant.
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2.3.2 Growth Performance During the Lactation Period
During the lactation period, LBW offspring exhibited an altered growth trajectory,
including a 13% reduction (p<0.01) in absolute growth rate (AGR; Table 2.2). However,
LBW offspring showed a 149.6% increase in their body weight over the course of the
lactation period, a 29% (p<0.0001) greater increase than the NBW offspring (Table 2).
The fractional growth rate was also 23% greater (p<0.0001) in LBW offspring, compared
to NBW (Table 2.2).

2.3.3 Growth Performance and Energy Intake Post-weaning
During the post-weaning period, NBW/CD offspring had an AGR of 7.38 ± 0.323
g from weaning until PND50, an AGR of 4.62 ± 0.23 g from PND51-110, and an AGR of
2.87 ± 0.47 g from PND111-145 (Figure 2.2A), ultimately reaching a body weight of
825.2 ± 28.3 g at the time of putdown. During the period from weaning until PND50,
NBW/WD offspring displayed a 27% reduction (p<0.01) in AGR, compared to NBW/CD
offspring, whereas LBW/WD offspring displayed a 34% reduction in AGR compared to
NBW/CD offspring (p<0.001; Figure 2.2A). No significant differences in mean AGR
were observed for the period from PND51-110. From PND111 to the time of putdown,
LBW/CD offspring displayed a 52% reduction (p<0.05) in AGR, compared to NBW/CD
offspring (Figure 2.2A). An overall reduction (p<0.01) in total mean AGR was also
observed in our WD-fed groups, independent of time.

Additionally, there was a

significant (p<0.01) interaction between time and our experimental groups (Figure 2.2A).
WD-fed offspring remained significantly (p<0.05) lighter than CD-fed offspring at the
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time of putdown, with body weights of NBW/WD: 732.3 ± 26.8 g; LBW/WD: 708.8 ±
19.8 g vs NBW/CD: 825.2 ± 28.3 g; LBW/CD: 747.9 ± 38.1 g. Compared to the
NBW/CD group, male LBW/WD animals had significantly (p<0.05) lower body weights
at putdown.
No significant differences in average food intake were observed throughout the
experimental period (Figure 2.2B). However, calorie consumption was significantly
(p<0.0001) higher in WD-fed offspring, independent of time (Figure 2.2C). From
weaning-PND50, calorie consumption was 23% higher in NBW/WD (p<0.05) and 36%
higher in LBW/WD (p<0.001) offspring compared to NBW/CD. From PND51-110,
calorie consumption was 26% higher in NBW/WD (p<0.05) compared to NBW/CD, and
from PND111-PND145, calorie consumption was 34% higher in NBW/WD (p<0.05) and
55% higher in LBW/WD (p<0.001) when compared to NBW/CD (Figure 2.2C).
The

feeding

efficiency

(grams

gained/day/calories

consumed/day)

was

significantly (p<0.0001) decreased in WD-fed offspring, in addition to a significant
(p<0.05) interaction with time (Figure 2.2D). From weaning-PND50, feeding efficiency
was reduced by 39% in NBW/WD (p<0.0001) and by 52% in LBW/WD (p<0.0001)
offspring compared to NBW/CD. From PND51-110, NBW/WD males showed a 35%
reduction in (p<0.01) feed efficiency compared to NBW/CD, whereas LBW/CD
offspring showed a 50% reduction in (p<0.01) feed efficiency from 111-PD, when
compared to NBW/CD (Figure 2.2D).
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A

B

C

D

Figure 2.2: Post-weaning Growth and Feeding Behaviour. A) Absolute growth rate
(AGR) = grams gained per day. B) Average food intake = grams of food
consumed/kilogram body weight. C) Calorie consumption = calories consumed per day.
D) Feeding efficiency = grams gained per day/calories consumed per day. Data presented
are the mean ± standard error (SEM) for n=11 NBW/CD, n=11 LBW/CD, n=9 NBW/WD
and n=7 LBW/WD offspring. Statistical significance was determined by Two-Way
ANOVA repeated measures, followed by post-hoc Tukey’s Test. Interaction: *p<0.05,
**p<0.01 significant interaction between experimental group and time; **p<0.01,
****p<0.0001 significant effect of experimental group, independent of time; ≠p<0.05,
≠≠p<0.01, ≠≠≠p<0.001, ≠≠≠≠p<0.0001 by post-hoc Tukey’s Test.
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2.3.4 Body Composition and Glucose Tolerance
Whole-body adiposity, as measured by computed tomography at PND110, was
significantly (p<0.01) reduced in WD-fed offspring, independent of birth weight (Figure
2.3). At tissue collection, mesenteric fat pad depot weights were significantly (p<0.001)
reduced in WD-fed offspring at the time of putdown (Table 2.3). Post-hoc analysis
demonstrated a significant (p<0.01) reduction of mesenteric fat pad mass in NBW/WD
and LBW/WD, when compared to NBW/CD offspring (Table 2.3).
No significant differences were observed in whole body glucose tolerance
following a bolus administration of glucose at PND60 (Figure 2.4A) or PND120 (Figure
2.4C). The clearance of glucose, as measured by the area under the curve, was also not
significantly altered by birth weight or postnatal diet at PND60 (Figure 2.4B) or PND120
(Figure 2.4D).
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Figure 2.3: Body Composition as Assessed by Computed Tomography Analysis.
Volumes occupied by muscle, bone and adipose tissue in the area between the proximal
tibia to base of skull was calculated using a MATLAB-derived application, normalized to
total body volume and expressed as a percentage. Data presented are the mean ±
standard error (SEM) for n=4-5 animals per group. Statistical significance was
determined by Two-Way ANOVA, followed by post-hoc Tukey’s Test. **p<0.01
significant effect of diet, independent of birth weight.

Inguinal
Fat
Mass

Brown
Fat
Mass

Epididymal
Fat Mass

Mesenteric
Fat Mass

Perirenal
Fat Mass

Retroperitoneal
Fat Mass

Leg
Fat
Mass

NBW/CD

0.011 ±
0.0007

0.010 ±
0.0010

0.012 ±
0.0009

0.015 ±
0.0010

0.007 ±
0.0009

0.009 ±
0.0004

0.002 ±
0.00009

LBW/CD

0.012 ±
0.0009

0.007 ±
0.0007

0.011 ±
0.0008

0.013 ±
0.0010

0.006 ±
0.0008

0.008 ±
0.0010

0.002 ±
0.00008

NBW/WD

0.011 ±
0.0006

0.009 ±
0.0010

0.011 ±
0.0008

0.010 ±
0.0010 ≠≠

0.005 ±
0.0004

0.008 ±
0.0005

0.002 ±
0.00017

LBW/WD

0.011 ±
0.0010

0.009 ±
0.0016

0.009 ±
0.0009

0.009 ±
0.0010 ≠≠

0.006 ±
0.015

0.008 ±
0.0010

0.002 ±
0.00019

ns

ns

ns

Diet: ***

ns

ns

ns

Males

Table 2.3: Adipose Tissue Depot Weights. Data presented are mean ± standard error
(SEM) for n=11 NBW/CD, n=11 LBW/CD, n=9 NBW/WD, n=7 LBW/WD offspring.
Statistical significance was determined by Two-Way ANOVA, followed by post-hoc
Tukey’s Test. Diet: ***p<0.001, significant effect of diet, independent of birth weight.
≠≠p<0.01, compared to NBW/CD by post-hoc Tukey’s Test. ns = not significant.
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A

B

C

D

Figure 2.4: Glucose Tolerance. A) Blood glucose values (mmol l-1) following an
intraperitoneal injection of 1g/kg of 50% dextrose solution at PND60. B) The area under
the glucose curve (AUGC) as a measurement of glucose clearance at PND 60. C) Blood
glucose values (mmol l-1) at PND120. D) The area under the glucose curve (AUGC) at
PND 120. Data presented are the mean ± standard error (SEM) or min. to max. box and
whisker plots for n=12 NBW/CD, n=12 LBW/CD, n=9 NBW/WD, n=7 LBW/WD.
Statistical significance was determined by Two-Way ANOVA, followed by post-hoc
Tukey’s Test.
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2.4 Discussion
Early-life growth and development, especially the contribution of the in utero
environment as a key contributor to later life metabolic outcome, has continued to gain
recognition and support in the global health and scientific community.38 Human and
animal studies have highlighted that insults affecting growth trajectory in utero and early
postnatal life have the potential to alter the programmed metabolic development of the
offspring, increasing their risk of developing serious metabolic consequences as they
interact with their postnatal environment. Therefore, the aim of the current study was to
assess growth and metabolic parameters of guinea pig offspring subjected to an adverse
in utero environment, and to assess the impact of the easily accessible Western diet in the
postnatal period on altered growth and metabolic parameters associated with a
developing MetS phenotype.
We chose to utilize a guinea pig model to investigate developmental
programming and the importance of the in utero environment on metabolic outcomes of
the offspring since, similar to humans and sheep, the guinea pig is a precocious species
that develops predominantly prenatally and is born relatively mature.39 Unlike other
rodent models, the guinea pig has a relatively long gestation (approximately 67-69
days),31 allowing for fetal adaptations to an adverse in utero environment. Invasion and
endocrine control of the placenta is also similar between human and guinea pig, further
validating the use of this model to investigate the fetal adaptations to chronic
perturbations in placental blood flow.40,41 The uterine artery ablation technique employed
has been shown to decrease delivery of oxygen and nutrients to the fetus via the
placenta,31 recapitulating the most common type of placental insufficiency characterized
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by placental hypoxia and abnormal uterine artery Doppler waveforms typically observed
in obstetrical clinics.42 Also of note, guinea pig lipid metabolism, fat deposition, as well
as metabolic responses to a high-fat diet, are similar to humans,43-45 further validating our
guinea pig model for investigating the relative impact of diet on aspects of postnatal
metabolism.
In our cohort, the uterine artery ablation surgery induced IUGR, and LBW
offspring below the 25th percentile displayed markers of growth restriction. Specifically,
LBW offspring exhibited a leaner phenotype as evidenced by the reduced birth
weight/birth length ratio. Similar reports of a lean phenotype have been observed in
other animal models of IUGR.16 Additional markers included a reduced biparietal
diameter, abdominal circumference, and crown-rump length, in accordance with other
guinea pig models of IUGR.16,18,31 Therefore, IUGR induces an altered body composition
as early as the time of birth when LBW offspring are compared to their NBW littermates.
During early life, the LBW offspring displayed an altered growth trajectory when
compared to NBW offspring. While the absolute growth rate (g/day) was lower in LBW
offspring, their percent increase in body weight and fractional growth rate throughout the
lactation period were greater than the NBW offspring. This accelerated growth trajectory
is characteristic of the period of rapid postnatal catch-up growth often observed in human
offspring of adverse in utero environments,12 and has also been observed in animal
models of IUGR.16,46 Fractional growth rate is commonly used as a marker of the
interaction between an offspring’s genetic growth potential and the nutritional
environment experienced. An increased fractional growth rate in early postnatal life has
been shown to be predictive of increased visceral obesity and impaired glucose tolerance
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in later life, early markers of MetS pathogenesis.47,48 Therefore, this accelerated growth
trajectory observed in our LBW offspring during the lactation period may be indicative of
rapid postnatal catch-up growth that predisposes these offspring to development of agerelated metabolic diseases.
Of particular concern to the global health community is the increased incidence of
worldwide childhood obesity along with the emergence of risk factors associated with
MetS in children and young adults.49 Independent of weight at birth, a high intake of
saturated fatty acids and simple sugars in addition to a lack of poly-unsaturated fatty
acids have been implicated in MetS pathogenesis.7,50 Diets high in saturated fats have the
propensity to promote ectopic lipid accumulation, disrupting normal metabolic function
and perpetuating a state of insulin resistance as an early indicator of MetS progression.51
Additionally, a high intake of simple sugars, namely glucose and fructose, is known to
disrupt whole body glucose homeostasis, altering insulin action in addition to promoting
ectopic lipid accumulation, two situations that have to the potential to promote insulin
resistance and progression of MetS.52 Furthermore, decreased consumption of polyunsaturated fatty acids also contributes to insulin resistance and a MetS phenotype by
altering the composition of skeletal muscle phospholipids and influencing insulin
action.52 With the goal of recapitulating the adverse metabolic consequences observed in
children and young adults, the composition of our WD replicates a “classic” WD, as
defined by a relatively large contribution of saturated fats, and added simple sugars,
namely fructose.
Following weaning, LBW offspring on a CD (LBW/CD) continued to display an
altered growth trajectory, such that at the time of putdown, there was no significant
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difference in weight between NBW/CD and LBW/CD offspring. This highlights that the
LBW/CD experienced a period of rapid postnatal growth that may be associated with an
increased development of risk factors associated with MetS.53 It is interesting to note that
these LBW/CD offspring did display a reduced absolute growth from PND111 to the
time of putdown, in addition to a reduced weight gain during this period despite
consuming a similar number of calories per day when compared to NBW/CD offspring.
This reduced weight gain during this period highlights the possible emergence of
metabolic deficiencies impairing efficient metabolism of caloric intake.

While this

reduction in growth during the plateau phase did occur, these offspring still reached
similar weights as their NBW counterparts, further supporting the notion that these
offspring experienced an early phase of rapid growth, a phenomena characteristic of
LBW postnatal growth following development in an adverse in utero environment.
In our cohort, WD-fed offspring remained significantly lighter than CD-fed
offspring throughout the duration of the post-weaning period, even at the time of
putdown. During the period of maximal growth, from weaning until PND50, WD-fed
offspring, irrespective of birth weight, displayed a reduced AGR, despite increased
calorie consumption.

This discrepancy, in addition to the reduced feed efficiency,

highlights an inefficiency affecting the ability of these animals to gain weight despite
consuming a more calorie-dense diet. Additionally, the LBW/WD offspring remained
significantly lighter throughout the duration of the experimental period, highlighting that
the consumption of a postnatal WD stunted the accelerated growth associated with
adverse growth in utero. Interestingly, this reduced body weight in the WD-fed offspring
occurred in conjunction with altered body composition and adiposity. At the whole body
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level, WD-fed offspring displayed reduced adiposity when assessed by computed
tomography. Additionally, when measured at the time of putdown, mesenteric fat pad
mass, a measure of visceral adiposity,54 was also reduced in the WD-fed offspring. This
reduction in adipose tissue mass, and overall reduction in adiposity, in addition to the
reduced body weight observed in these offspring, highlight that components of the
postnatal WD alters the body composition and metabolic profile of these offspring.
The diet of modern society is characterized by excess fats and sugars, particularly
fructose and saturated fats, which have been associated with not only a rise in obesity
rates, but also higher incidence of insulin resistance and type 2 diabetes.7,9 While fructose
is typically associated with an increase in adiposity and insulin resistance,54 rodent
studies that introduce fructose from an early age have observed similar reductions in
body weight and adiposity.55-57 It has been suggested that early introduction of fructose in
the diet is associated with development of fructose intolerance and subsequently an
impairment of weight gain.58,59 Early in life, intestinal levels of GLUT5, the main
fructose transporter, are reported to be low, impairing fructose transport and contributing
to the development of fructose intolerance should administration of fructose be in large
quantities during this period of development.60
While recent evidence suggests that the excess fat consumed in energy-dense
diets may be repartitioned to other tissues, namely liver, negatively impacting metabolic
health,61 excess consumption of fructose on its own has also been associated with
alterations in liver metabolism. In non-human primates fed a high-fructose diet for 7
years, poor hepatic health as assessed by serum biochemistry was associated with
histological liver damage, without significant increases in body weight.62

The
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consumption of a fructose-rich diet for greater than the equivalent of one year also
resulted in development of lipidosis in the liver, promoting development of hepatic
steatosis and metabolic disease.62 Human subjects consuming fructose have also been
shown to display significantly higher rates of hepatic de novo lipogenesis in comparison
to those consuming glucose alone,63 highlighting the liver as an important metabolic
organ impacted by fructose consumption that may perpetuate the MetS phenotype.
Consumption of fructose and saturated fatty acids in combination has also been reported
to alter body composition and endocrine function of adult offspring. Studies where
rodents were fed 30% fructose with or without addition of saturated fats displayed
reduced fat accumulation and impaired insulin sensitivity in male offspring weaned onto
the fructose plus saturated fat diet for 12 weeks.64 This study highlights that an early
exposure to a combination of fructose and saturated fat modulates adiposity and
endocrine function, promoting a MetS phenotype.64
Another important hallmark in the pathogenesis of MetS is dysregulation of
glucose homeostasis, namely the development of hyperglycemia and glucose
intolerance.6 Typically, studies assessing glucose homeostasis as a component of the
MetS phenotype focus on the adult period,65,66 with few studies investigating the impact
of being weaned onto a poor diet on the development of glucose intolerance. Studies
have shown that children growing up in families consuming poor diets are exposed
earlier in life to these energy-dense diets, and continue this consumption pattern
throughout postnatal life.67,68 Therefore, an important aspect of our study was to
investigate the impact of being weaned onto a poor diet on glucose tolerance as a
component of the MetS phenotype. In our cohort, whole-body glucose tolerance as
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assessed by IPGTT was not affected by birth weight or postnatal diet. However, at this
age similar results have been observed in other models of young IUGR offspring, namely
those in sheep and rodents.46,69 The young age of our offspring, approximately equivalent
to 18-20 years in the adult,33 may explain the maintenance of glucose homeostasis we
have observed. In a study examining 20-year-old men who were born low birth weight,
glucose tolerance was similarly maintained, however reduced insulin sensitivity was also
observed.70 Maintenance of glucose tolerance has also been observed in young offspring
of type 2 diabetic mothers; however progression to a state of insulin resistance does occur
with age.71 Therefore, the young age of our offspring highlights that the progression
towards a MetS phenotype may be in its early stages. It is important to note that
reductions in peripheral insulin-stimulated glucose uptake, namely in liver, heart, adipose
tissue and skeletal muscle, are typically observed before overt whole-body changes in
glucose tolerance.72 Young LBW men with normal whole body glucose disposal have
also been observed to display reduced forearm glucose uptake, and molecular changes in
insulin signaling, highlighting an early step in disease pathogenesis that may continue to
fail with age.

21,73,74

Overall, while we do not observe overt features of whole-body

glucose intolerance at this stage, there may be underlying alterations at the physiological
level that predispose these offspring to development of later life MetS as they continue to
interact with their postnatal environment.
While our animals remain small and non-obese at this young age, they do show
evidence of metabolic disruptions.

Previous studies from our laboratory have

demonstrated increased aortic wall stiffening in LBW offspring,75 which was further
exacerbated by postnatal consumption of a WD.32 These LBW-induced alterations are an
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early sign of vascular dysfunction that may be associated with risk factors for the
development of later life cardiovascular disease. Additionally, we have observed altered
adipose tissue lipid metabolism in conjunction with increased visceral adiposity in the
LBW offspring,19 predisposing these offspring to later life dyslipidemia associated with
MetS. Therefore, the presence of these previously characterized metabolic disruptions, in
addition to the altered growth and metabolic parameters assessed here, support the theory
that the in utero environment and growth trajectory are important players in determining
postnatal disease risk.
In summary, our data suggest that body composition, growth, and feed efficiency
are altered following development in an adverse in utero environment. Additionally,
interaction with a postnatal nutritional environment characterized by nutrient excess
impairs growth and further alters the body composition of the offspring. This altered
growth and body composition is associated with an increased predisposition for these
offspring to develop age-related metabolic diseases, supporting the concept of
developmental programming of postnatal metabolism.
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Chapter 3:
Indicators of Skeletal Muscle Mitochondrial Dysfunction and Impaired Insulin
Signaling Occurs in Low Birth Weight Guinea Pigs, and Following Postnatal
Exposure to a “Western” Diet

Data presented in this chapter is in preparation for submission.
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3.1 Introduction
Epidemiological studies have highlighted that an adverse in utero environment
that restricts fetal growth, culminating in intrauterine growth restriction (IUGR) and low
birth weight (LBW), increases the propensity for the offspring to develop age-related
metabolic and cardiovascular diseases in later life.1-4 Before overt manifestations of
metabolic syndrome (MetS) are apparent, insulin resistance is typically observed,
highlighting that the development of insulin resistance is a critical precursor to the
pathophysiological development of MetS and establishing its use as an early marker of
metabolic disease development and progression.5 Insulin resistance is classically
characterized as a metabolic state in which peripheral tissues, particularly skeletal
muscle, are no longer responsive to insulin, preventing insulin-stimulated glucose uptake
and perpetuating a state of hyperglycemia.6 Insulin sensitivity is primarily assessed in
skeletal muscle, since this is the location for the majority of insulin-stimulated glucose
uptake, accounting for up to 70% of whole body glucose clearance.7
Typically, insulin resistance development is associated with poor diet choices and
sedentary lifestyles;8,9 however, the in utero environment is now recognized as a key
player in insulin resistance pathogenesis.3,5,10 Indeed, LBW offspring have been shown
to display a 7-fold increased risk of being insulin resistant by young adulthood.11 More
recently, the EPOCH study highlighted higher fasting insulin levels and homeostatic
model assessment of insulin resistance (HOMA-IR) values indicative of impaired insulin
sensitivity as early as 10 years of age in IUGR-exposed children.12

These studies

highlight that metabolic adaptations initiated in utero can have life-long metabolic
consequences.
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The origins of skeletal muscle insulin resistance in the adult population are
complex and multifactorial, however energy-dense, high-fat/high-sugar “Western” diets
have been implicated as contributing factors in the pathophysiological progression to
insulin resistance.9 Consumption of this diet generates a surplus of circulating fatty acids,
ultimately leading to ectopic lipid accumulation in non-adipose tissues, such as skeletal
muscle, and impaired mitochondrial function.13 Skeletal muscle lipid accumulation in
animal models has been associated with impairments in insulin signaling, with long-chain
acyl-CoAs, triglycerides (TG) and diacylglycerol (DAG) highlighted as key mediators of
this phenomenon. The saturation of the lipids making up the TG pool is also a critical
factor contributing to skeletal muscle insulin resistance. A higher proportion of saturated
fatty acids in the TG pool reduces lipid oxidation, allowing accumulation of DAG and
ceramide.14 Accumulation of these lipotoxic intermediates has been associated with
classical markers of insulin resistance.15

These markers include reductions in the

phosphorylation of the insulin receptor and decreased activation of phosphoinositide-3
(PI-3) kinase, which is responsible for phosphorylating and activating Protein Kinase B
(Akt). Activation of Akt requires phosphorylation at both Thr308 and Ser473; therefore a
reduction in phosphorylation at either site may be indicative of impaired signaling.16
Active Akt is responsible for phosphorylating and activating the Akt substrate of 160 kDa
(AS160) at Thr642, allowing insertion of glucose transporters (GLUT4) into the plasma
membrane.15,17 Decreases in the phosphorylation and activation of the above
intermediates occur in conjunction with an increase in the inhibitory phosphorylation of
Insulin Receptor Substrate-1 (IRS-1) at Ser307, ultimately resulting in a decrease in
insulin-stimulated glucose uptake through GLUT4 transporters.15 Insulin resistance can
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occur at any level of the insulin signaling cascade, from the initial binding of insulin to its
receptor to alterations in the phosphorylation cascade responsible for initiating glucose
uptake.18 When these molecular alterations associated with insulin resistance occur in
conjunction with hyperinsulinemia and/or maintenance of whole body glucose tolerance,
it is associated with a pre-diabetic state characteristic of an early stage of disease
pathogenesis.19,20
An alternate theory for development of impaired insulin sensitivity implicates
alterations in skeletal muscle mitochondrial metabolism.

It has been recently

demonstrated that adults with high intakes of high-fat food and reduced physical activity
display impaired mitochondrial function.21

Mitochondrial dysfunction is defined as a

decrease in mitochondrial substrate oxidation resulting from a general decrease in
oxidative phosphorylation.22 In order to initiate the oxidation process, long-chain acylCoAs in the skeletal muscle must enter the mitochondria as acylcarnitines.
Acylcarnitines are formed when long-chain acyl-CoAs have their CoA exchanged for
carnitine, catalyzed by subcellular carnitine palmitoyltransferase 1 (CPT1), which is rate
limiting step of oxidation, and classically used as a surrogate marker of oxidative
capacity.13,21,23,24

Once the acylcarnitines have crossed into the mitochondria via

carnitine acetyltransferase, they are converted back to acyl-CoAs by carnitine
palmitoyltransferase 2 (CPT2) so the long-chain acyl-CoAs can undergo β-oxidation.24
The process of β-oxidation successively reduces the length of the acyl-CoA carbon chain
by 2 carbons through the actions of a series of enzymatic reactions catalyzed by very
long-chain acyl-CoA dehydrogenase (VLCAD), medium-chain acyl-CoA dehydrogenase
(MCAD), and 3-ketoacyl-CoA thiolase (KT) among others.21,25 Acetyl-CoA, the products
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of β-oxidation, are then fed through the TCA cycle, generating carbon dioxide and
electron carriers such as NADH and FADH2. These electron carriers then enter the
electron transport chain in order to generate ATP as an energy source through oxidative
phosphorylation.26 Accumulation of acylcarnitines in tissue is reported to be indicative
of impairment in the utilization of the substrates generated through β-oxidation, and the
presence of fatty acids that are incompletely oxidized.23 It has also been suggested that
these acylcarnitines, when present in excessive amounts, have the ability to promote
alterations in the phosphorylation status of key insulin signaling intermediates through
the actions of stress-induced kinases,27 highlighting acylcarnitine accumulation secondary
to mitochondrial dysfunction as key mediators of the pathogenesis of insulin resistance.
Recently, evidence has suggested that in utero influences and secondary insults in
adult life may have a synergistic effect, further exacerbating an already dysfunctional
system and promoting earlier onset of MetS.10

Of late, an increased incidence of

childhood obesity has largely been attributed to early introduction of energy-dense diets
and sedentary behavior.28 However, genetics and the contribution of the in utero
environment to epigenetic alterations to metabolic function cannot be negated when
assessing whether these children are at increased risk of developing symptoms associated
with MetS at an earlier age.29 Therefore, the present study is aimed to identify alterations
in skeletal muscle mitochondrial lipid metabolism following IUGR independently, and in
conjunction with early postnatal exposure to a Western diet.
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3.2 Materials and Methods
3.2.1 Ethics Statement
Animal care, maintenance and surgical procedures were conducted in accordance
with the guidelines of the Canadian Council on Animal Care. All procedures were
approved by The University of Western Ontario Animal Use Subcommittee (Appendix
II).

3.2.2 Animal Handling
Time-mated pregnant Dunkin-Hartley guinea pigs (Charles River Laboratories,
Wilmington, MA, USA) where housed in a constant temperature (20°C) and humidity
(30%) controlled environment with 12h light/dark cycle. All animals had ad libitum
access to standard guinea pig chow (LabDiet diet 5025) and tap water.
All pregnant guinea pigs underwent uterine artery ablation, as previously
described,30 to induce uteroplacental insufficiency and intrauterine growth restriction
(IUGR). At mid-gestation (~32 days, term ~67 days), sows were anesthetized in an
anesthetic chamber (4-5% isoflurane with 2L/min O2, followed by 2.5-3% isoflurane with
1L/min O2 for maintenance).

Immediately following induction of anesthesia, a

subcutaneous injection of Rubinol (Glycopyrrolate, 0.01mg/kg, Sandoz Can Inc.,
Montreal, QC) was administered. A midline incision was made below the umbilicus,
exposing the bicornate uterus. Arterial vessels feeding each horn of the uterus were
identified, and every second branch was cauterized using an Aaron 2250 electrosurgical
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generator (Bovie Medical, Clearwater, FL). Immediately after surgery, a subcutaneous
injection of Temgesic (Buprenorphine, 0.025mg/kg, Schering-Plough Co., Kenilworth,
NJ) was administered, and monitoring continued following surgery. Sows delivered
spontaneously at term, at which time pup weight, length, abdominal circumference and
biparietal distance were measured. Following the pupping period, all birth weights were
collated and if birth weight was below the 25th percentile these guinea pigs were allocated
to the low birth weight (LBW) group, and if birth weight was between the 25th and 75th
percentile these pups were allocated to the normal birth weight (NBW) group (Figure
2.1). Based on these criteria, LBW pups were below 80g, and NBW pups were above
90g, in accordance with previously reported data.31,32 Low body weight is often
recognized as a crude measure of an adverse in utero growth environment. An additional
measure of adverse growth in utero, and potentially more reflective of the growth
conditions experienced in utero is birth weight/birth length,33 which was also measured
(Chapter 2).
Pups remained with their dams during the 15-day lactation period. Five days
prior to weaning, all pups were introduced to a synthetic control diet (Harlan Laboratories
TD.110240: Table 2.1) and weaned on PND15 into individual cages. At this time, guinea
pig offspring were randomized to either a control (CD, Harlan Laboratories TD.110240:
Table 2.1) or a Western (WD, Harlan Laboratories TD.110239: Table 2.1). To avoid
litter effects, only one LBW and one NBW animal from a single litter was assigned to
each diet. Only male pups were examined for this study in order to prevent confounding
factors related to estrous cycle and hormone profile of female offspring.
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3.2.3 Assessment of Whole-Body Glucose Tolerance
At PND60 and PND120, intraperitoneal glucose tolerance tests (IPGTTs) were
performed to assess whole body glucose tolerance as previously described in section
2.2.5.

3.2.4 Assessment of Skeletal Muscle Glucose Uptake
At PND50 and PND110, pups underwent positron-emission tomography (PET)
scans in order to assess in vivo glucose uptake at the level of the skeletal muscle. Prior to
scanning, body weights and blood glucose measurements were taken. Throughout the
duration of the scans, physiological parameters including heart rate, respiration rate and
oxygen saturation were monitored to ensure well-being of the animal.

Pups were

anesthetized in an anesthetic chamber (4-5% isoflurane with 2L/min O2) then transferred
to a tight fitting nose cone (2.5-3% isoflurane with 1L/min O2 for maintenance). While
anesthetized, pups were injected with ~25kBq/kg (0.2-0.3mL) of

18

F-fluoro-deoxy-

glucose (FDG) via the pedal vein. Following injection, pups were allowed to recover for
40 minutes, before being anesthetized again (4-5% isoflurane with 2L/min O2) and placed
on a micro-PET scanner (GE eXplore Vista, GE Healthcare) fitted with a nose cone (2.53% isoflurane with 1L/min O2 for maintenance). Emission scans for the leg regions were
conduced for 20 minutes, then reconstructed in 3D mode.

Resulting images were

analyzed with a custom MATLAB-designed program (MATLAB; MathWorks Inc., MA,
USA), where regions of interest were drawn around the muscles of the hind-limb.
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Measurements of Standard Uptake Value (SUV) were obtained by applying FDG dosage
and body weight of the pup to the following equation:34,35

𝑆𝑈𝑉 =   

𝐴𝑐𝑡𝑖𝑣𝑖𝑡𝑦  𝑖𝑛  𝑇𝑖𝑠𝑠𝑢𝑒
(𝐼𝑛𝑡𝑟𝑖𝑛𝑠𝑖𝑐  𝐴𝑐𝑡𝑖𝑣𝑖𝑡𝑦 𝐵𝑜𝑑𝑦 𝑊𝑒𝑖𝑔ℎ𝑡)

3.2.5 Tissue Collection
At PND145, pups were sacrificed by CO2 inhalation36 following an overnight fast.
Gastrocnemius muscle, a representative muscle with mixed composition of oxidative and
glycolytic fibers,37 was removed and trimmed of excess fat and connective tissue, then
flash frozen in liquid nitrogen for subsequent analysis.

3.2.6 Protein Extraction and Immunoblotting
Gastrocnemius samples (~50mg each) were homogenized in 0.5mL ice-cold lysis
buffer (pH 7.4, 50mM Tris-HCl, 1% NP-40, 0.5% Sodium-deoxycholate, 150mM NaCl,
0.1% sodium dodecyl sulfate) containing protease inhibitor cocktail (Cocktail set 1,
Calbiochem, Bilerica, MA) and phosphatase inhibitors (1 M NaF, 0.2 M Na2VO4, 0.2 M
NaPP and 1 M Na2Gly). Homogenates were incubated on ice for 15 minutes, then
subjected to sonication with 3-5 bursts at 30% output (MISONIX: Ultrasonic liquid
processor), followed by centrifugation at 15,000g for 30 min at 4°C. The supernatant
was collected and Pierce BCA Protein Assay (Thermo Scientific, Waltham MA) was
employed for protein quantification.
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Protein samples were separated using 7.5%, 10% or 12% Bis-Tris gels, and
transferred onto Immobilon transfer membranes (EMD Millipore, Billerica, MA) via wet
transfer. Consistent protein loading and sufficient transfer of proteins was confirmed
using 1× Amido Black stain and images were captured using a Versadoc System (BioRad, Mississauga, Ontario). Membranes were blocked overnight at 4°C with Trisbuffered saline (TBS)/0.1% Tween 20 (Thermo Fisher Scientific, Waltham, MA)
containing 5% skim milk, 5% bovine serum albumin (BSA; AMRESCO, Solon, Ohio) or
10% BSA as indicated in Table 3.1.

Following blocking, primary antibodies were

applied for 1h at room temperature at dilutions specified in Table 3.1. The blots were
then washed in TBS/0.1% Tween 20 and incubated at 1h room temperature with the
appropriate secondary conjugated antibody (Santa Cruz Biotechnology, Santa Cruz, CA)
in TBS/0.1% Tween 20 containing 5% skim milk or BSA. The blots were then washed in
TBS/0.1% Tween 20 and protein bands were revealed by Luminata Forte Western Blot
HRP Substrate (EMD Millipore, Billerca, MA) and captured using a Versadoc System
(Bio-Rad, Mississauga, Ontario).

All images were visualized using Quantity One

software (Bio-Rad, Mississauga, Ontario), and densitometry values (arbitrary units) were
determined using Image Lab 4.0 software (Bio-Rad, Mississauga, Ontario).

The

abundance of target proteins was expressed relative to Amido Black densitometry values
for proteins of the same molecular weight.38
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3.2.7 RNA Extraction and Quantitative Real-Time PCR (qRT-PCR)
Total RNA was extracted from gastrocnemius tissue by homogenizing ~20mg in
1mL Trizol (Invitrogen, Carlsbad, CA) and following the manufacturers protocol. Total
RNA was subsequently treated with deoxyribonuclease for 30 minutes to eliminate
genomic DNA. Quantification of RNA was performed with the ND-1000 NanoDrop
spectrophotometer (Thermo Fisher Scientific, Rochester, NY). Each sample was also
assessed for RNA integrity using 1.2% agarose electrophoresis with RedSafe™ (iNtRON
Biotechnology, Sangdaewon-Dong, Joongwon-Ku, Sungnam, Kyungki-Do, 462-120,
KOREA). Complementary DNA was synthesized from 2µg of purified RNA, reversetranscribed using M-MLV Reverse Transcriptase (Life Technologies, Burlington, ON)
and a C1000 Thermal Cycler (Bio-Rad, Mississauga, ON). All primers were designed
from guinea pig (cavia porcellus) sequences using NCBI/Primer-BLAST tool (Table
3.2). Standard curves for each primer pair (three pairs for each gene) were generated
from serial dilutions of cDNA for determination of primer efficiencies. PCR efficiencies
for each primer set were 90-105% (Table 3.2). Melting curve analysis and presence of a
single amplicon at the expected size in a 1.8% agarose gel were used to confirm
amplification of a single product. cDNA products were used as templates for qRT-PCR
assessment of gene expression using the SYBR green system (SensiFast™ Sybr No-Rox
Mix; Bioline, London, United Kingdom) on a Bio-Rad CFX384 Real-Time system
instrument (Bio-Rad, Mississauga, ON). Each sample was run in triplicate. Forty cycles
of amplification were performed, with each cycle consisting of: denaturation at 95°C for
15s, annealing at the pre-determined temperature for each primer set denoted in Table 3.2
for 20s, and extension at 72°C for 20s. Control samples containing no cDNA were used
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to confirm absence of DNA contamination. The transcript level of target genes was
normalized to β-actin; there were no differences in the expression of β-actin between
experimental groups. The fold expression of each individual target gene was determined
by the 2-ΔCt method.39

3.2.8 Thin Liquid Chromatography and Gas Chromatography
Total lipids were extracted from gastrocnemius muscle (~160mg), using a
protocol adapted from Klaiman et al.40 Briefly, tissue samples were homogenized in
850µl 1:1 chloroform:methanol (v/v) containing 0.1% butylated hydroxytoluene (BHT).41
Following homogenization, 8.5mL of 2:1 chloroform:methanol (v/v)+0.1% BHT was
added to each sample. 1.7mL of 0.25% KCl was added to separate the aqueous solutes,
then incubated at 70°C for 10 minutes. Once the samples were cooled, they were
centrifuged at 2000rpm for 5 minutes, and the aqueous layer was removed.

The

remaining solution, containing lipids, was dried under a gentle stream of N2, and
resuspended in 1mL chloroform. 20µL of total lipids were removed for subsequent
analyses and diluted to a concentration of 2µg/µL. The remaining sample was dried
again under a gentle stream of N2.
Separation and analysis of lipid classes was accomplished by thin layer
chromatography-flame ionization detection (TLC-FID) using the Iatroscan MK-6
TLC/FID Analyzer System (Shell-USA, Federicksburg, VA). The system is composed of
10 quartz rods that are 15cm in length and 0.9mm in diameter, coated with a 75µm layer
of porous silica-gel particulates that are 5µm in diameter42 (Shell-USA, Federicksburg,
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VA). Prior to application of samples, chromarods were repeatedly blank scanned in order
to burn off any impurities and activate the rods. 1µl of the 2µg/µL lipid sample or the
reference standard was spotted onto the rods. Rods were developed in a TLC chamber
with benzene:chloroform:formic acid (70:30:0.5 v/v/v) to separate the neutral lipids until
the solvent front reached the 100 mark on the rod holder. Rods were subsequently
removed and dried at 60°C in a rod dryer (TK8, Iatron Inc, Tokyo, Japan) for 5 minutes.
Rods were analyzed using the following settings: 2L/min atmospheric air, 160mL/min
hydrogen, scanning speed of 3s/cm. Area under the curve for the peaks of interest were
integrated using PeakSimple 3.29 Software (SRI Instruments, CA) and expressed as a
percentage of the total area under the curve for all peaks analyzed.
In preparation for gas chromatography, the total lipids were fractioned using
Supelco Supelclear LC-NH2 sPE columns (Supelco, Bellefonte, PA). Total lipid samples
were resuspended in chloroform to a concentration of 10mg/mL. Once the columns were
conditioned, 300µL of suspended sample was added and allowed to flow through the
column, then centrifuged at 1000rpm for 1min. Neutral lipids were eluted with 1.8mL of
2:1 chloroform:isopropanol (v/v), followed by centrifugation at 1000rpm for 1min. Nonesterified fatty acids were eluted with 1.6mL 98:2 isopropyl ether:acetic acid (v/v),
followed by centrifugation at 1000rpm.

Phospholipids were eluted with 3mL of

methanol, followed by centrifugation at 1000rpm for 1min.

Each sample was

subsequently dried under a gentle flow of N2. 300µg of each sample was then methylated
by adding 200µL of Meth-HCl to the dried sample and incubated at 90°C for 45min.
800µL of water, followed by 500µL of hexane was added to each sample, with the
hexane layer extracted and put in a fresh tube. Following hexane extraction, samples
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were dried under a gentle flow of N2, and resuspended in dichloromethane for injection
into a 6890N gas chromatograph (Hewlett Packard, Palo Alto, CA, USA) with a J&W
Scientific High Resolution Gas Chromatography Column (DB-23, Agilent Technologies)
and a flame ionization detector. Fatty acids were identified by comparison of the relative
retention time with known standards (Supelco 37 component FAME mix, and Supelco
PUFA No.3, from Menhaden Oil).

3.2.9 Extraction and LC-MS/MS Method for the Analysis of Amino Acids and
Acylcarnitines
Acylcarnitine and amino acid analysis was performed by the Analytical Facility
for Bioactive Molecules, The Hospital for Sick Children, Toronto, Canada.
Ground tissue was weighed out and a solution of 1:1 water:methanol was added to
yield 25mg/mL. Samples were then homogenized and kept on ice. An equivalent of 5mg
of homogenized tissue was added to an Eppendorf tube with an acylcarnitine internal
standard (IS) mixture (NSK-B, Cambridge Isotopes) and an amino acid IS mixture
(Arginine-13C6, ADMA-d7, citrilline-d7, glutamic acid-d2, ornithine-d7, and leucine-d10,
Cambridge Isotopes and CDN Isotopes). Samples and standard mixtures were then
acidified with 60µL of 0.1% formic acid and then protein was precipitated using 1mL of
0.3% formic acid in acetonitrile. Tubes were then vortexed and centrifuged at 10,000g
for 10 minutes at 4°C. Supernatants were transferred to conical glass tubes and the
remaining pellet in the Eppendorf was re-suspended in an additional 1mL 0.3% formic
acid in acetonitrile and vortexed and centrifuged again. The combined supernatants were
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dried under a gentle flow nitrogen gas. Samples and standards were derivatized with
100µL butanolic-HCL 3N for 20 minutes at 65°C. Solvent was then removed under a
gentle flow nitrogen gas and samples were reconstituted in 200µL MPB (see below) and
transferred to auto sampler vials. 10µL of the reconstituted sample was diluted 50x in the
same solution for amino acid analysis.
Extracted samples were injected onto a Kinetex HILIC 50 x 4.6 mm 2.6 µm
column (Phenomenex) connected to an Agilent 1290 HPLC system attached to a Q-Trap
5500 mass spectrometer (AB Sciex, Framingham, MA). Injected samples were eluted
with a gradient of mobile phases MPA: 90/10 5 mM ammonium formate pH
3.2/acetonitrile and MPB: 10/90 5mM ammonium formate pH 3.2/acetonitrile. For
Acylcarnitines, the gradient started at 4% MPA for 1 minute, increasing to 45% for 0.65
min, holding for 0.05 min and then returning to 4% MPA for the remaining 3 minutes.
For amino acids, the 50 x diluted samples were eluted with a gradient of MPA starting at
4% for 2.5 minutes and increasing to 75% MPA until 6 minutes, holding at 75% MPA for
1 minute, and then returning to 4% over the final 2.5 minutes. Mass transitions were
monitored for each sample and compared against known standard mass transitions for
species analyzed.43 Data was collected and analyzed using Analyst v1.6 (AB Sciex,
Framingham, MA). Qualitative area ratios were determined for each species examined.43

3.2.10 Statistical Analyses
Data presented are mean ± standard error (SEM) or min. to max. box and whisker
plots. Statistical significance was determined by two-way ANOVA followed by post-hoc
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Tukey’s test to assess the effects of birth weight and postnatal diet, using GraphPad
Prism 6 (GraphPad Software, San Diego, CA). Tests of correlation were performed with
the Spearman rank-order test. Values of p<0.05 were considered statistically significant.
A principle component (PC) analysis (PCA) of the acylcarnitine and amino acid
measurements was performed (SPSS Statistics, version 21.0; IBM SPSS, Armonk, NY)
to reduce the dimensionality of the data set while retaining as much of the variance as
possible. The metabolic PCs, defined as linear, orthogonal (uncorrelated) combinations
of the original metabolites, were ordered according to their decreasing ability to explain
variance in the original data set. Only principle components with eigenvalues greater
than 1 were retained. The cumulative variance explained by the 9 PCs included in the
resultant analysis was 87.6%. The data set was then rotated using an orthogonal varimax
procedure.

To facilitate biological interpretation of the PCs, the associated weight

loading factors for each metabolite were examined and metabolites with a loading score
greater than 0.5 are reported for each factor. Tests of main effects of birth weight, diet,
and birth weight by diet interactions were performed using two-way ANOVA.
Associations between factor scores and immunoblot measurements are reported as
Spearman rank correlation coefficients.
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Protein

Species

Dilution

IRβ

Rabbit
Monoclonal
Rabbit
Monoclonal
Rabbit
Monoclonal
Rabbit
Monoclonal
Rabbit
Monoclonal
Rabbit
Monoclonal
Rabbit
Monoclonal
Rabbit
Monoclonal
Rabbit
Monoclonal
Rabbit
Monoclonal
Rabbit
Polyclonal
Mouse
Monoclonal
Rabbit
Monoclonal
Mouse
Monoclonal
Mouse
Monoclonal
Mouse
Monoclonal

1:1000

Blocking
Solution
5% BSA

1:1000

5% BSA

1:1000

5% BSA

1:1000

5% BSA

1:1000

5% BSA

1:500

5% BSA

1:1000

5% BSA

1:1000

5% BSA

1:1000

5% BSA

1:1000

5% BSA

1:1000

5% BSA

1:1000

1:1000

5% Skim
Milk
5% Skim
Milk
5% Skim
Milk
5% BSA

1:1000

10% BSA

Rabbit
Polyclonal
Rabbit
Polyclonal
Rabbit
Polyclonal
Rabbit
Polyclonal
Rabbit
Polyclonal
Rabbit

1:1000

5% BSA

1:1000

5% BSA

1:1000

5% BSA

1:500

5% Skim
Milk
5% Skim
Milk
5% Skim

pIRβ (Tyr
1150/1151)
IRS1
pIRS1 (Ser
307)
p85
p110
Pan AKT
pAKT (Ser
473)
pAKT (Thr
308)
AS160
pAS160
(Thr 642)
GLUT4
GLUT2
GLUT5
JNK
pJNK (Thr
183/Tyr
185)
IKKβ
pIKKβ (Ser
176/180)
PKC-θ
CD36
FATP1
(ACSVL5)
FATP4

1:1000
1:4000

1:1000
1:1000

Company
Cell Signaling
Technology
Cell Signaling
Technology
Cell Signaling
Technology
Cell Signaling
Technology
Cell Signaling
Technology
Cell Signaling
Technology
Cell Signaling
Technology
Cell Signaling
Technology
Cell Signaling
Technology
Cell Signaling
Technology
Cell Signaling
Technology
ABCAM

Catalogue
No.
3025
3024
2382
2381
4257
3011
4691
4060
2965
2670
4288
ab166704

Santa Cruz
Biotechnology
Pierce
Biotechnologies
Santa Cruz
Biotechnology
Santa Cruz
Biotechnology

sc-9117

Cell Signaling
Technology
Cell Signaling
Technology
Cell Signaling
Technology
Santa Cruz
Biotechnology
Santa Cruz
Biotechnology
Santa Cruz

2678

MA1-036
sc-7345
sc-6254

2694
2059
sc-9154
sc-25541
sc-25670
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(ACSVL4)
CPT1
PPARα
PGC1α
SIRT1
SIRT3
FOXO1
pFOXO1
(Ser256)
Anti-Rabbit
Secondary
Anti-Mouse
Secondary
Anti-Goat
Secondary

Polyclonal
Mouse
Monoclonal
Mouse
Monoclonal
Rabbit
Polyclonal
Mouse
Monoclonal
Rabbit
Polyclonal
Rabbit
Polyclonal
Rabbit
Polyclonal
Donkey

1:1000

Milk
5% Skim
Milk
5% Skim
Milk
5% Skim
Milk
5% Skim
Milk
5% Skim
Milk
5% BSA

1:1000

5% BSA

1:10,000

-

Donkey

1:10,000

-

Donkey

1:20,000

-

1:500
1:500
1:500
1:2000
1:1000

Biotechnology
Santa Cruz
Biotechnology
ABCAM

sc-393070
ab2779

Santa Cruz
Biotechnology
Santa Cruz
Biotechnology
ABCAM

sc-13067

Cell Signaling
Technology
Cell Signaling
Technology
Santa Cruz
Biotechnology
Santa Cruz
Biotechnology
Santa Cruz
Biotechnology

9454

sc-74465
ab86671

9461
sc-2077
sc-2314
sc-2020

Table 3.1: Specifications and Catalog Numbers of Antibodies Used for
Immunoblotting.
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Gene
VLCAD
MCAD
KT
PDK4
CPT1b
PGC1α
PPARα
SIRT1
SIRT3
β-actin

Accession
No.
XM_003466
183.2
XM_003479
087.2
XM_003464
099.2
XM_003475
111.2
XM_003461
559.1
XM_003467
408.2
NM_001173
004.1
XM_005005
505.1
XM_004999
541.1
NM_001172
909.1

Anneal
Temp
(°C)

Forward
Sequence
(5’è3’)

Reverse Sequence
(3’è5’)

59

CAAACTGGCAGTG
ACGGCT
CGAGTTGACCGAA
CAGCAGA
TAAGGTCCTACGC
AGTGGTTG
GCAGTGGTCCAAG
ATGCCTT
AGCTCCCCATTCC
TAGCAGA
CAAGACCAGTGAA
TTGAGGG
AGATCCAGAAAAA
GAACCGC
TTGCAACTGCATC
TTGCCTG
CATGGCGGATCTG
CTACTCA
AAGAGATGTGGCC
TCAAAGC

TTGGTGGGGGTCAGA
CTGTA
CAACAGGCATTTGCC
CCAAG
CTCCATAAGCCCTCT
TCCCAC
TGGTGTTCAACTGTT
GCCCT
CGCTGAGCATTCGTC
TCTGA
CATCCTTTGGGGTCTT
TGAG
TTTTGCTTTCTCAGAC
CTCG
TCATGGGGTATGGAA
CTTGGAA
AGGCTGCATGTTGTG
GTTTG
CAGGAACAGGCCGTA
GAGTG

59
59
59
59
56
56
58
58
59

Table 3.2: Primers Used for Analysis of Gene Expression by qRT-PCR.

Efficiency
91.2%
94.4%
90.8%
94.2%
96.7%
92.5%
91.8%
103.8%
93.8%
100.6%
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3.3 Results
3.3.1 Glucose Homeostasis is Maintained at 4 Months of Age
Intraperitoneal glucose tolerance challenges were performed to assess whole body
glucose tolerance. No significant differences were observed in whole body glucose
handling following a glucose load at either PND 60 (Figure 3.1A) or PND120 (Figure
3.1C). The whole body clearance of glucose, as measured by the area under the curve,
was also not significantly altered by birth weight or postnatal diet at either PND60
(Figure 3.1B) or PND120 (Figure 3.1D).
Glucose uptake at the level of the skeletal muscle was assessed using

18

F-FDG

PET and measuring the standard uptake value of radioactivity observed during the scans.
No significant differences in skeletal muscle glucose uptake were observed due to birth
weight or postnatal diet at either PND50 (Figure 3.2A) or PND110 (Figure 3.2B).
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A

B

C

D

Figure 3.1: Whole-Body Glucose Tolerance. A) Blood glucose values (mmol l-1)
following an intraperitoneal injection of 1g/kg of 50% dextrose solution at PND60. B)
The area under the glucose curve (AUGC) as a measurement of glucose clearance at PND
60. C) Blood glucose values (mmol l-1) at PND120. D) The area under the glucose curve
(AUGC) at PND 120. Data presented are the mean ± standard error (SEM) or min. to
max. box and whisker plots for n=6 NBW/CD, n=6 LBW/CD, n=6 NBW/WD, n=5
LBW/WD. Statistical significance was determined by Two-Way ANOVA, followed by
post-hoc Tukey’s Test.
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A

B

Figure 3.2: Skeletal Muscle Glucose Uptake at A) Postnatal Day 50 and B) Postnatal
Day 110. Standard Uptake Value (SUV) = image derived radioactivity / (injected
activity/body weight). Data presented are min. to max. box and whisker plots for n=6
NBW/CD, n=6 LBW/CD, n=6 NBW/WD, n=5 LBW/WD. Statistical significance was
determined by Two-Way ANOVA, followed by post-hoc Tukey’s Test.
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3.3.2 Skeletal Muscle Lipid Profile
Using thin layer chromatography-flame ionization detection (TLC-FID),
separation and analysis and lipid classes in gastrocnemius muscle was accomplished.
There were no significant differences in the accumulation of triglycerides (TG),
cholesterol (Chol), or diacylglycerol (DAG) due to birth weight or postnatal diet (Figure
3.3).
The intermuscular fatty acid pool was profiled using gas chromatography. In the
neutral lipid fraction, there was a significant (p<0.001) increase in C14:0 in WD-fed
animals, a significant

(p<0.001) decrease in C18:2n6c in WD-fed animals, and a

significant (p<0.01) decrease in C18:3n3 in WD-fed animals (Figure 3.4A). In the
phospholipid fraction there was a significant (p<0.001) decrease in C16:0 and a
significant (p<0.01) increase in C18:1n7 in WD-fed animals (Figure 3.4B).
alterations in the fatty acid composition were influenced by birth weight alone.

No
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Figure 3.3: Relative Abundance of Lipid Species in Gastrocnemius Muscle.
Measured by thin liquid chromatography-flame ionization detection. Data presented are
mean ± standard error (SEM) for n=6 NBW/CD, n=6 LBW/CD, n=6 NBW/WD, n=5
LBW/WD. Statistical significance was determined by Two-Way ANOVA, followed by
post-hoc Tukey’s Test.

A

B

Figure 3.4: Fatty Acid Profile of Lipids in Gastrocnemius Muscle. A) Neutral lipid
fraction and B) Phospholipid fraction, measured by gas chromatography. Data presented
are mean ± standard error (SEM) for n=6 NBW/CD, n=6 LBW/CD, n=6 NBW/WD, n=5
LBW/WD. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 by Two-Way ANOVA
followed by post-hoc Tukey’s Test.
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3.3.3 Skeletal Muscle Insulin Signaling is Disrupted in WD-fed and LBW offspring
The phosphorylation of the β-subunit of the insulin receptor (IRβ) is required for
its activation and propagation of downstream signaling events.44 Skeletal muscle of WDfed, and LBW offspring displayed a 46% (p=0.1729) and 67% (p=0.1460) reduction of
phosphorylation of IRβ, respectively (Figure 3.5B).
In contrast to tyrosine phosphorylation, which activates IRS-1, serine
phosphorylation is inhibitory, preventing activation of PI3-kinase and downstream
signaling events.44 In WD-fed offspring, there was a significant (p<0.01) increase in
inhibitory serine phosphorylation of IRS-1 (Figure 3.5C).
Full activation of PI3-kinase requires coordination between the p85 regulatory
subunit and the p110 catalytic subunit,45 in order to phosphorylate downstream
components of the insulin signaling pathway. Total protein levels of the p85 regulatory
subunit were significantly (p<0.01) reduced in LBW-offspring, irrespective of postnatal
diet (Figure 3.5D). Total protein levels of the p110 catalytic subunit were reduced by
37% (p=0.0977) in LBW-offspring, irrespective of postnatal diet (Figure 3.5E).
Protein Kinase B/Akt is phosphorylated by PI3-kinase at two resides, Ser473 and
Thr308, that are both required for full activation of this protein.46 At the Ser473 residue,
phosphorylation was significantly (p<0.05) reduced in WD-fed offspring, and reduced
(p=0.059) in LBW-offspring, irrespective of postnatal diet (Figure 3.5F). Additionally, a
potential interaction between birth weight and postnatal diet (p=0.0803) was observed.
At the Thr308 residue, there was a significant (p<0.001) increase in phosphorylation in
WD-fed offspring (Figure 3.5G)
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One of the final steps required for GLUT4 translocation is activation of Akt
Substrate of 160 kDa (AS160), which is accomplished by Akt-mediated phosphorylation
at Thr642.47 Phosphorylation of AS160 at Thr642 was significantly (p<0.05) reduced in
LBW/CD offspring when compared to NBW/CD offspring (Figure 3.5H). Additionally,
a significant (p<0.01) interaction between birth weight and postnatal diet was observed.
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G

pAS160 160 kDa
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Amido Black

H

Figure 3.5: Expression and Phosphorylation of Key Proteins Involved in Insulin
Signaling. A) Insulin Receptor phosphorylation, B) Insulin Receptor Substrate-1 (IRS-1)
phosphorylation, C) p85 subunit of PI3-Kinase, D) p110 subunit of PI3-Kinase, E)
Protein Kinase B/Akt phosphorylation at Ser-473, F) Protein Kinase B/Akt
phosphorylation at Thr-308, G) Akt Substrate of 160 kDa (AS160) phosphorylation, H)
Working schematic for molecular manifestations of insulin resistance. Data presented are
min. to max. box and whisker plots for n=6 NBW/CD, n=6 LBW/CD, n=6 NBW/WD,
n=5 LBW/WD. Representative blots of the respective proteins are below each group.
Statistical significance was determined by Two-Way ANOVA, followed by post-hoc
Tukey’s Test. *p<0.05, **p<0.01, ***p<0.001 significant main effect of birth weight,
diet or interaction; ≠p<0.05 by post-hoc Tukey’s Test.
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3.3.4 Glucose Transporter Profiles are Altered in WD-fed and LBW Offspring
While there were no significant differences observed in total skeletal muscle
GLUT4 expression (Figure 3.6A), total GLUT2 expression was significantly (p<0.001)
reduced in WD-fed offspring. However, birth weight significantly (p<0.01) increased
expression of GLUT2 (Figure 3.6B). When compared to NBW/CD offspring, LBW/CD
offspring showed a significant (p<0.05) increase in GLUT 2 expression. Alternatively,
total GLUT5 expression was significantly increased in WD-fed offspring (p<0.01), as
well as LBW offspring (p<0.05; Figure 3.6C). Similar to GLUT2 expression levels,
GLUT5 was significantly (p<0.05) increased in LBW/CD offspring when compared to
NBW/CD offspring.
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Figure 3.6: Expression of Glucose Transporters. A) GLUT4, B) GLUT2, C) GLUT5.
Data presented are min. to max. box and whisker plots for n=6 NBW/CD, n=6 LBW/CD,
n=6 NBW/WD, n=5 LBW/WD. Representative blots of the respective proteins are below
each group. Statistical significance was determined by Two-Way ANOVA, followed by
post-hoc Tukey’s Test. *p<0.05, **p<0.01, ***p<0.001 significant main effect of birth
weight, diet or interaction; ≠p<0.05 by post-hoc Tukey’s Test.
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3.3.5 Disruption of FOXO1 Signaling Occurs in WD-fed Offspring
In skeletal muscle of WD-fed offspring, there were significantly (p<0.001)
reduced total protein levels of the transcription factor FOXO1 (Figure 3.7A).
Additionally, there was significantly (p<0.05) increased phosphorylation of FOXO1 at
Ser256, promoting nuclear export and preventing activation of its target genes48 (Figure
3.7B), a pattern not observed in LBW offspring.
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FOXO1 82 kDa
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B
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FOXO1 82 kDa
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Figure 3.7: Expression of A) Total Levels and B) Phosphorylation of FOXO1
Protein. Data presented are min. to max. box and whisker plots for n=6 NBW/CD, n=6
LBW/CD, n=6 NBW/WD, n=5 LBW/WD. Representative blots of the respective
proteins are below each group. Statistical significance was determined by Two-Way
ANOVA, followed by post-hoc Tukey’s Test. *p<0.05, ***p<0.001, significant main
effect of diet.

107

3.3.6 Stress-Induced Kinases are Activated in WD-fed and LBW Offspring
Stress-induced kinases, including JNK, IKKβ and PKC-θ, are known to be
activated in situations of oxidative stress or lipid accumulation.24,49 A differential pattern
of stress-induced kinase activation was present in WD-fed vs LBW offspring. Activation
of JNK through phosphorylation at Thr183/Tyr185 was significantly (p<0.0001) increased
only in WD-fed offspring (Figure 3.8A), whereas phosphorylation levels were minimal in
LBW/CD offspring. Activation of JNK has been documented to promote inhibitory
serine phosphorylation of IRS-1.50 In our study, an increased JNK phosphorylation ratio
correlated with an increased IRS-1 serine phosphorylation ratio (r=0.554, p=0.006,
Figure 3.14C).
Furthermore, the activation of IKKβ through phosphorylation at Ser176/180 was
significantly (p<0.0001) increased in WD-fed and LBW offspring (Figure 3.8B). A
significant (p<0.0001) interactive effect between birth weight and postnatal diet was also
observed.
Lastly, total protein levels of PKC-θ were significantly (p<0.01) higher in LBWoffspring, irrespective of postnatal diet.

When compared to NBW/CD offspring,

LBW/CD offspring showed a robust (p<0.05) increase in total PKC-θ protein levels.

108

A

pJNK 54 kDa
JNK 54 kDa
Amido Black

B

pIKKβ 87 kDa
IKKβ 87 kDa
Amido Black

C

PKC-θ 85 kDa
Amido Black

Figure 3.8: Expression and Phosphorylation of Key Stress-Induced Kinases. A) JNK
phosphorylation, B) IKKβ phosphorylation, C) Total PKC-θ levels. Data presented are
min. to max. box and whisker plots for n=6 NBW/CD, n=6 LBW/CD, n=6 NBW/WD,
n=5 LBW/WD. Representative blots of the respective proteins are below each group.
Statistical significance was determined by Two-Way ANOVA, followed by post-hoc
Tukey’s Test. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 significant main effect of
birth weight, diet or interaction; ≠p<0.05, ≠≠≠≠p<0.0001 by post-hoc Tukey’s Test.
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3.3.7 Fatty Acid Transporters are Differentially Altered in WD-fed and LBW
Offspring
CD36, one transporter by which fatty acids can enter skeletal muscle, exhibited
significantly (p<0.0001) reduced total protein levels in WD-fed offspring (Figure 3.9A).
However, birth weight significantly (p<0.05) increased protein levels of CD36, such that
LBW/CD offspring showed significantly (p<0.05) increased expression when compared
to NBW/CD offspring (Figure 3.9A).
In contrast, FATP1 was significantly (p<0.01) increased in WD-fed offspring
(Figure 3.9B).

Additionally, a significant (p<0.01) interactive effect between birth

weight and postnatal diet was observed, such that LBW/WD offspring displayed
significantly (p<0.001) increased FATP1 expression when compared to LBW/CD
offspring (Figure 3.9B). Expression levels of FATP4 were not altered by birth weight or
postnatal diet (Figure 3.9C).
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Figure 3.9: Fatty Acid Transporters. A) CD36, B) FATP1, C) FATP4. Data presented
are min. to max. box and whisker plots for n=6 NBW/CD, n=6 LBW/CD, n=6
NBW/WD, n=5 LBW/WD. Representative blots are below each group. Statistical
significance was determined by Two-Way ANOVA, followed by post-hoc Tukey’s Test.
*p<0.05, **p<0.01, ****p<0.0001 significant main effect of birth weight, diet or
interaction; ≠p<0.05, ≠≠≠p<0.001 by post-hoc Tukey’s Test.
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3.3.8 Mitochondrial β-oxidation is Disrupted in LBW Offspring
The rate limiting step of mitochondrial β-oxidation, CPT1-catalyzed transport of
acylcarnitines into the mitochondria, is often used as a marker of mitochondrial oxidative
capacity.51 We observed a significant (p<0.05) decrease in CPT1b mRNA transcript
abundance in LBW offspring, irrespective of postnatal diet (Figure 3.10A). A significant
(p<0.05) decrease was also observed at the protein level in LBW offspring (Figure
3.10B).
Up-regulation of PDK4 inactivates the pyruvate dehydrogenase complex,
initiating a switch from glucose catabolism to lipid oxidation.52 However, PDK4 mRNA
expression levels were not altered by birth weight or postnatal diet (Figure 3.10C). To
initiate lipid oxidation and the cycle of β-oxidation, acyl-CoA must be dehydrogenated,
which is accomplished by enzymes specific to the length of the chain being oxidized.25
Both VLCAD, which dehydrogenates the very-long acyl-CoA chains, and MCAD, which
dehydrogenates the medium acyl-CoA chains, mRNA levels were not altered by birth
weight or postnatal diet (Figures 3.10D and 3.10E, respectively). The final enzyme in the
β-oxidation cycle is KT, which catalyzes the removal of the 2-carbon acetyl-CoA that is
fed into downstream TCA cycle.25

KT mRNA levels were significantly (p<0.05)

decreased in skeletal muscle of LBW offspring, irrespective of postnatal diet (Figure
3.10F).
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Figure 3.10: Expression of Key Enzymes Involved in Mitochondrial β-Oxidation. A)
CPT1b mRNA expression, B) CPT1 protein expression, C) PDK4 mRNA expression, D)
VLCAD mRNA expression, E) MCAD mRNA expression, F) KT mRNA expression.
Data presented are min. to max. box and whisker plots for n=6 NBW/CD, n=6 LBW/CD,
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n=6 NBW/WD, n=5 LBW/WD. Representative blots of the respective proteins are below
each group. Statistical significance was determined by Two-Way ANOVA, followed by
post-hoc Tukey’s Test. *p<0.05, significant main effect of birth weight.

3.3.9 Transcription Factors Regulating Mitochondrial β-oxidation are Reduced in
WD-fed and LBW Offspring
PGC-1α and PPARα are well-known transcription factors that regulate aspects of
mitochondrial lipid oxidation.53 While skeletal muscle PGC-1α mRNA expression was
similar among groups (Figure 3.11A), protein levels were significantly (p<0.001) reduced
in WD-fed offspring, and reduced by 15% (p=0.0797) in LBW offspring (Figure 3.11B).
A similar pattern was observed for PPARα, where mRNA expression was not
different among groups (Figure 3.11C).

However, protein levels were similarly

significantly (p<0.001) reduced in WD-fed offspring, and reduced by 26% (p=0.0845) in
LBW offspring (Figure 3.11D).
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Figure 3.11: Expression of Transcription Factors Regulating Mitochondrial βOxidation. A) PGC-1α mRNA expression, B) PGC-1α protein expression, C) PPARα
mRNA expression, D) PPARα protein expression. Data presented are min. to max. box
and whisker plots for n=6 NBW/CD, n=6 LBW/CD, n=6 NBW/WD, n=5 LBW/WD.
Representative blots of the respective proteins are below each group. Statistical
significance was determined by Two-Way ANOVA, followed by post-hoc Tukey’s Test.
***p<0.001, significant main effect of diet.
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3.3.10 Sirtuins Regulating Mitochondrial Biogenesis are Reduced in WD-fed
Offspring
Skeletal muscle sirtuins are a family of transcription factors regulating
mitochondrial biogenesis and function.54 SIRT1, which is predominantly found in the
cytosol, is a key player involved in regulation of lipid oxidation.55

While mRNA

expression levels of SIRT1 were not different between experimental groups (Figure
3.12A), SIRT1 protein levels were significantly (p<0.001) reduced in WD-fed offspring
(Figure 3.12B).

Additionally, LBW/CD offspring displayed a significant (p<0.05)

increase in SIRT1 protein levels when compared to NBW/CD offspring, and a significant
(p<0.05) interactive effect between birth weight and postnatal diet was also observed
(Figure 3.12B).
SIRT3, which is exclusively located in the mitochondria, is a key player in
regulating mitochondrial oxidation at the level of β-oxidation and the electron transport
chain.56 Similar to SIRT1, SIRT3 mRNA expression was not affected by birth weight or
postnatal diet (Figure 3.12C). However, protein levels of SIRT3 were significantly
(p<0.05) reduced in WD-fed offspring (Figure 3.12D).
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Figure 3.12: Expression of Skeletal Muscle Sirtuins. A) SIRT1 mRNA expression, B)
SIRT1 protein expression, C) SIRT3 mRNA expression, D) SIRT3 protein expression.
Data presented are min. to max. box and whisker plots for n=6 NBW/CD, n=6 LBW/CD,
n=6 NBW/WD, n=5 LBW/WD. Representative blots of the respective proteins are below
each group. Statistical significance was determined by Two-Way ANOVA, followed by
post-hoc Tukey’s Test. *p<0.05, ***p<0.001, significant main effect of diet or
interaction. ≠p<0.05, by post-hoc Tukey’s Test.

117

3.3.11 Markers of Mitochondrial Dysfunction are Present in WD-fed and LBW
Offspring
Recently, acylcarnitine metabolites have emerged as strong markers of
mitochondrial stress and dysfunction.21,23,57,58 Accumulation of even-chain acylcarnitines
represents partially oxidized intermediates of β-oxidation, whereas accumulation of oddchain acylcarnitines represents catabolism of amino acids.21
In

gastrocnemius

muscle,

medium-chain

acylcarnitines

(C6-C12)

were

significantly (p<0.05) increased following consumption of a postnatal WD (Figure
3.13A). Additionally, a significant (p<0.05) effect of birth weight upon accumulation of
C8 and C10 was also observed (Figure 3.13A).

While not reaching statistical

significance, a potential interactive effect between birth weight and postnatal diet was
observed in C8-C12 species, with LBW/WD offspring tending to exhibit increased
accumulation of C8 and C12 (p=0.0622 and p=0.0554, respectively) when compared to
NBW/WD offspring (Figure 3.13A). Levels of C2 acylcarnitine, the end product of
complete β-oxidation,25 were significantly (p<0.05) reduced in WD-fed offspring.
Similarly, long-chain acylcarnitines (C14-C18:1) were significantly (p<0.0001)
increased following consumption of a postnatal WD (Figure 3.13B). Significant (p<0.05)
effects of birth weight were observed in C14:1, C16, C18 species, whereas birth weight
alone tended to induce accumulation of C18:1 and C18:3 species (p=0.0763 and
p=0.0906, respectively; Figure 3.13B). A significant (p<0.05) interactive effect between
birth weight and postnatal diet was observed for C14:1 acylcarnitine. In LBW/WD
offspring, significant (p<0.05) accumulation of C14:1 and C16 was noted, while C18
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tended (p=0.0592) to accumulate, when compared to NBW/WD offspring (Figure 3.13B).
A significant (p<0.01) reduction of C20:4 acylcarnitine levels was also observed in WDfed offspring (Figure 3.13B)
Inhibition of NADH-linked β-hydroxy fatty acyl-CoA oxidation is known to
promote accumulation of hydroxyacylcarnitines.59 We observed significant (p<0.05)
accumulation of the 3-β-hydroxylated forms of C12, C14, C16, C18 and C18:1 in
response to WD-feeding (Figure 3.13C). Birth weight also induced a significant (p<0.05)
accumulation of C16-OH (Figure 3.13C). A potential interactive effect between birth
weight and postnatal diet (p=0.0615) was observed in C12-OH species (Figure 3.13C).
A cluster of amino acids has recently been identified that strongly predict risk of
developing diabetes and impaired insulin action, including the branched-chain amino
acids (leucine, isoleucine, valine), as well as tyrosine and phenylalanine.58 In our model,
we observed increased (p=0.0572) levels of leucine in LBW offspring, irrespective of
postnatal diet (Figure 3.13D). We also observed reduced (p=0.0734) levels of isoleucine
in gastrocnemius muscle of WD-fed offspring (Figure 3.13D). Lastly, we observed a
significant (p<0.05) accumulation of phenylalanine in WD-fed offspring, and a trend
(p=0.0878) towards accumulation in LBW offspring (Figure 3.13D).
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Figure 3.13: Acylcarnitine and Amino Acid Levels in Gastrocnemius Muscle. A) C2
& medium-chain acylcarnitines, B) long-chain acylcarnitines, C) hydroxylated
acylcarntines, D) gluconeogenic amino acids as measured by LC-MS/MS. Data
presented are mean ± standard error (SEM) for n=5-8 animals per group. Statistical
significance was determined by Two-Way ANOVA, followed by post-hoc Tukey’s Test.
*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001, significant main effect of birth weight,
diet, or interaction. ≠p<0.05, by post-hoc Tukey’s Test. Common names for the
acylcarnitine short hands can be found in Appendix I.
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3.3.12 Principle Components Analysis (PCA) of Acylcarntine and Amino Acid
Levels
We employed PCA as an unbiased data reduction strategy to determine a model
of how acylcarnitine and amino acid metabolism relates to the observed alterations in
insulin signaling described above. Nine factors were identified, explaining 87.6% of the
total variance in the model. Features of the top 4 PCs are described in Table 3.3.
The first PC (PC1; medium- and long-chain acylcarnitines) was composed of
even-chain acylcarnitines ranging from C8 through C18, in addition to the unsaturated
acylcarnitines C14:1, C16:1 and C18:1. Additionally, C2 (acetylcarnitine) was also a
part of this component, however the negative loading factor suggests that levels of C2
would decrease as levels of the other components of this cluster increase, similar to the
accumulation profile we observed in Figure 3.13. A significant (p<0.0001) main effect of
diet was observed for the components of this factor, highlighting postnatal diet as a major
contributor to the acylcarnitine species associated with this component.

PC2

(hydroxylated acylcarnitines) was composed predominantly of the hydroxylated
acylcarnitines derived from C4, C12-C18 and C18:1, with contributions from C4 as well
as C6. A potential contribution (p=0.076) of postnatal diet was observed for this factor.
PC3 (poly-unsaturated long-chain acylcarnitines) was composed of C18:2, C18:3, C20:4
and C22:5 acylcarnitine species, with a significant (p=0.022) contribution of postnatal
diet to this cluster. PC4 (gluconeogenic amino acids) was composed of the amino acids
leucine, isoleucine, valine, tyrosine and phenylalanine. Birth weight was a potential
(p=0.075) contributor to the species observed in this factor.
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Since accumulation of medium- and long-chain acylcarnitines is a welldocumented marker of mitochondrial dysfunction,21,22 we decided to focus further
analysis on PC1. PC1 scores were moderately correlated with increased JNK
phosphorylation as a measure of its activation (r=0.658, p=0.001; Figure 3.14A).
Additionally, PC1 scores were modestly correlated with increased inhibitory serine IRS-1
phosphorylation (r=0.466, p=0.025; Figure 3.14B).
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Factor
PC1, medium- &
long-chain
acylcarnitines;
eigenvalue 12.6
(43.40%)

PC2,
hydroxylated
acylcarnitines;
eigenvalue 3.9
(13.71%)

Metabolite
Description
C2 (-0.715)
C8 (0.556)
C10 (0.797)
C12 (0.886)
C14 (0.801)
C16 (0.929)
C18 (0.836)
C14:1 (0.766)
C16:1 (0.877)
C18:1 (0.921)
C4 (0.865)
C6 (0.784)
C4-OH (0.721)
C12-OH (0.723)
C14-OH (0.783)
C16-OH (0.741)
C18-OH (0.814)
C18:1-OH
(0.764)

PC3, polyunsaturated
long-chain
acylcarnitines;
eigenvalue 3.3
(11.36%)

C18:2 (0.807)
C18:3 (0.813)
C20:4 (0.716)
C22:5 (0.925)

PC4,
gluconeogenic
amino acids;
eigenvalue 2.2
(7.53%)

Leu (0.723)
Ile (0.603)
Val (0.801)
Tyr (0.554)
Phe (0.673)

P-values for Main Effect
Birth Weight
Diet
Birth Weight
and Diet

p=0.273

p<0.0001

p=0.469

p=0.415

p=0.076

p=0.569

p=0.775

p=0.022

p=0.996

p=0.075

p=0.587

p=0.459

Table 3.3: Results of the Exploratory PCA on Acylcarnitine Levels. Eigenvalues and
percent contribution to total sample variance is presented for the first 4 principle
components of the model. Individual features of each component are displayed, along
with rotated loading coefficients when greater than 0.5. Values in parentheses next to
each metabolite are the loading coefficient from the PCA model, which is a measure of
the importance of each metabolite to the factor. Parenthetical values next to the
eigenvalue represent the percentage of the total sample variation for each factor.
Common names for the acylcarnitine short hands can be found in Appendix I.
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Figure 3.14: Correlation Analyses. A) Correlation of JNK phosphorylation and Factor 1
score, B) Correlation of IRS-1 phosphorylation and Factor 1 score, C) Correlation of
IRS-1 phosphorylation and JNK phosphorylation. Regression lines with 95% confidence
intervals of the mean are shown.

124

3.4 Discussion
With the recent surge of research investigating the developmental origins of
health and disease, the contribution of the in utero environment and its ability to
modulate growth is a well-established determinant of later life disease risk. However, the
mechanisms by which adverse growth in utero may induce later life insulin resistance
and the progression to MetS remain elusive. In this study, we sought to determine the
relative contribution of the in utero environment upon disrupted skeletal muscle lipid
metabolism as a component of the pathophysiological progression of insulin resistance.
Additionally, with the increasing availability of high-fat/high-sugar diets and their early
introduction during the postnatal period, we sought to determine whether early
consumption of these diets would have a synergistic effect following a LBW outcome,
promoting early markers of insulin resistance.

3.4.1 Skeletal Muscle Insulin Signaling and Glucose Homeostasis in LBW offspring
While we did not see alterations in whole-body glucose tolerance or skeletal
muscle glucose uptake in our cohort, we did observe molecular disruptions to the skeletal
muscle insulin signaling cascade, a documented component of pre-diabetes.9,20 LBW was
associated with a reduction in the phosphorylation of the insulin receptor, as well as
decrease in total protein content of the p85 and p110 subunits of PI3-kinase, highlighting
impaired activation, in addition to reductions in phosphorylation of Akt at Ser473, and
AS160 at Thr642. Similar to our observations, reduced levels of p85 and p110 have been
observed in both animal models of IUGR, as well as young adult men born LBW.60-62
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This impairment of PI3-kinase actions in these other models of IUGR occurred in
conjunction with impaired phosphorylation of Akt and AS160 in response to insulin
stimulation.63 In young adulthood, the molecular alterations observed in human offspring
also occurred with maintenance of whole-body glucose tolerance, similar to what we
have observed in our cohort.60,61 It has been postulated that changes in expression and
phosphorylation of the insulin signaling intermediates precedes the development of overt
insulin resistance and glucose intolerance,61 providing a molecular signature associated
with early stages of disease progression.64 Therefore, the persistent changes in the insulin
signaling pathway, in conjunction with maintenance of glucose homeostasis highlight
that at this young age, our guinea pigs are in an early-stage of insulin resistance
pathogenesis resembling a pre-diabetic state;20 however, we speculate that with time
insulin sensitivity will decrease and disrupt glucose homeostasis, similar to human
reports4,61 and animal models of older LBW offspring.65
While whole-body glucose tolerance is maintained in young adolescent men born
LBW, reduced glucose uptake in the muscles of the forearm have been observed.60 This
reduced glucose uptake is typically associated with reductions in skeletal muscle GLUT4
content,60,61,63 reducing insulin-stimulated glucose uptake into the muscle. Interestingly,
we did not observe any significant differences in total GLUT4 protein content in our
cohort, nor did we observe deficiencies in skeletal muscle glucose uptake as measured by
18

F-FDG PET scans. However, we observed significant increases of GLUT2 and GLUT5

total protein content in LBW offspring. Additionally, we observed significant decreases
in GLUT2 content in WD-fed animals, in conjunction with significant increases in
GLUT5 content, which may be able to provide an avenue for compensation in order to
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maintain skeletal muscle glucose uptake following consumption of a postnatal WD. In
the skeletal muscle the more significantly expressed GLUTs include GLUT4, GLUT5
and GLUT12;66

however, GLUT2 is a low-affinity glucose transporter, known to

facilitate minimal glucose uptake into skeletal muscle in order to maintain glucose
homeostasis.67 Additionally, GLUT5, while typically considered to be the main fructose
transporter in skeletal muscle,68 also has the ability to facilitate glucose uptake.66 It is
even responsive to the actions of insulin, activating the GLUT5 promoter region to
induce its expression in response to the hormonal milieu.66 Therefore, the observed
increases in total GLUT5 protein content of LBW and WD-exposed offspring highlight a
potential compensatory mechanism at play in our model, similar to that observed in the
muscle of type 2 diabetic patients, aimed at maintaining glucose homeostasis at this
age.69

3.4.2 Mechanisms Underlying Molecular Alterations in Insulin Signaling
We next sought to assess the mechanisms by which the alterations in skeletal
muscle insulin signaling may occur. Literature investigating the mechanisms underlying
insulin resistance pathogenesis secondary to high-fat feeding highlighted three candidate
stress-induced kinases that may be activated in situations of oxidative stress or lipid
overload.24 Following chronic exposure to high-fat diets, activation of JNK through
phosphorylation at Thr183/Tyr185 has been associated with increased inhibitory serine
phosphorylation of IRS-1 at Ser307.50 Similarly, in our offspring exposed to postnatal
WD diets, we saw a robust activation of JNK, which was modestly correlated with the
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observed inhibitory serine phosphorylation of IRS-1. However, phosphorylation of JNK
was not detectable in our LBW/CD offspring, prompting further investigation into other
stress-kinases that may be activated in LBW situations.

In addition to significant

activation of IKKβ in our WD-fed offspring, we also observed significant activation in
our LBW/CD offspring, in addition to a LBW-specific increase in total levels of PKC-θ.
Each of these stress-kinases have been well documented to have the ability to promote
inhibitory serine phosphorylation of IRS-1 in situations of oxidative stress,49 disrupting
downstream insulin signaling events. Overall, we observed differential activation of
stress-induced kinases in LBW and WD-fed offspring, highlighting that activation of
stress-induced kinases may be environment specific depending on the mechanism by
which the stress occurs. Additionally, in LBW/WD offspring, where activation of stresskinases due to a LBW outcome and postnatal consumption of a WD may occur, an
interactive effect is possible, promoting further disruption to skeletal muscle insulin
signaling.
Activation of stress-kinases is also known to occur secondary to lipid overload
and accumulation of toxic lipid intermediates, including triglycerides, DAG and
ceramides.15,49 Therefore, we sought to determine the relative contribution of lipotoxic
intermediates to the alterations in insulin signaling and the activation of stress-kinases
observed above. We did not observe any significant accumulation of triglycerides or
DAG in the skeletal muscle of WD-fed offspring, contrary to other high-fat diet-induced
insulin resistance models.14,15 Interestingly, altered insulin sensitivity in the absence of
DAG accumulation has been observed in pre-diabetic men,70 highlighting alternative
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mechanisms may be at play early in disease progression, namely accumulation of other
lipotoxic intermediates such as ceramides or acylcarnitines.49
We also profiled the composition of the fatty acids present in the skeletal muscle
by gas chromatography. A higher percentage of saturated fatty acids in the neutral lipid
fraction has been associated with reduced insulin sensitivity,14 similar to the
accumulation of C14:0 we observed in our WD-fed offspring. We also observed
reductions in the omega-6 and omega-3 poly-unsaturated fatty acids in the neutral lipid
fraction, which have also been implicated in reduced insulin sensitivity.14,71 Unsaturated
fatty acids have the ability to protect against lipotoxicity by promoting uptake into an
inert triglyceride pool that is not esterified into intermediates, namely ceramide.14
Additionally, a higher proportion of saturated fatty acids in this lipid pool have been
associated with higher ceramide content due to de novo ceramide synthesis.72 These
alterations in fatty acid composition favouring ceramide accumulation have the potential
to reduce insulin sensitivity by reducing Akt activation.49 Overall, the alterations we
observed in the skeletal muscle of WD-fed offspring mirrored the composition of the
dietary fats present in the WD (Chapter 2, Table 2.1). Additionally, we did not observe
any alterations in the fatty acid profile due to birth weight alone, prompting further
investigation into mitochondrial metabolism as an alternative theory to explain the
observed defects in insulin signaling.
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3.4.3 Mitochondrial Oxidation in Response to LBW and Postnatal WD
The first step in the mitochondrial oxidation of lipids is entry of fatty acids into
the skeletal muscle through the coordinated actions of the fatty acid transporters
FAT/CD36, FATP1 and FATP4.73 In our model, total protein levels of CD36 were
significantly reduced in offspring consuming a postnatal WD; however FATP1 was
significantly increased in these same offspring.

Conversely, in LBW/CD offspring,

CD36 levels were significantly increased, but FATP1 levels were significantly decreased.
Not only does this data suggest differential expression of fatty acid transport proteins in
response to birth weight and postnatal diet, but also highlights a mechanism by which
fatty acid transport into the skeletal muscle can continue without impediment.
Additionally, recent evidence suggests both CD36 and FATP1 are localized to the
mitochondria in addition to the plasma membrane,74,75 providing a concentrated supply of
long-chain fatty acids for entry into mitochondria and subsequent oxidation. Therefore,
the differential expression of FATP1 and CD36 also support the notion that entry of fatty
acids into the cell for oxidation is not compromised at this stage of disease progression,
preventing accumulation of fatty acids as triglycerides or toxic lipid intermediates.
However, we did observe accumulation of acylcarnitine intermediates in skeletal
muscle of WD-fed offspring, as well as LBW offspring. These intermediates are known
to accumulate in situations of mitochondrial dysfunction and incomplete fatty acid
oxidation, where they are indicative of impairment of substrate flux through the TCA
cycle and oxidative phosphorylation.21,57,58 Therefore, we investigated the enzymatic
reactions involved in β-oxidation and the regulation of the oxidative process in order to
shed light on possible mechanisms underlying the observed accumulation of
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acylcarnitines. At both the mRNA and protein level, CPT1, the rate-limiting step of the
oxidation process,25 was reduced in LBW offspring, irrespective of postnatal diet.
Additionally, mRNA levels of KT, the enzyme responsible for catalyzing the removal of
acetyl-CoA from the fatty acid chain,25 was reduced in LBW offspring. These defects in
the oxidative process would slow down the rate of β-oxidation and impair substrate
utilization through the remaining steps of the oxidative process, preventing complete
oxidation of the fatty acid chains. However, the reduced levels of these oxidative
enzymes were LBW-specific, highlighting that the accumulation of acylcarnitines in the
WD-fed offspring is likely due to alternate defects in other components along the
oxidative pathway.

3.4.4 Regulation of Mitochondrial Biogenesis and Oxidative Function
In order for fatty acids to be completely oxidized, the tight coordination of a
number of transcription factors regulating mitochondrial biogenesis and oxidative
function is required. PPARα is one such transcription factor that is highly expressed in
oxidative tissues, including skeletal muscle, which is known to induce activation of genes
involved in β-oxidation.24,76 However, in order for full activation of PPARα target genes,
coordination with PGC-1α is required.53,77 PGC-1α also has the ability to independently
activate genes involved in the TCA cycle and oxidative phosphorylation, promoting
complete oxidation of lipid substrates.55 Consumption of high-fat diets is known to
reduce protein levels of PGC-1α21,57 reducing lipid oxidation and promoting
accumulation of acylcarnitine intermediates indicative of mitochondrial dysfunction. We
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observed similar reductions in total protein levels in our WD-exposed offspring. Recent
studies have also reported reduced PGC-1α protein levels in gastrocnemius muscle of
adolescent low birth weight offspring.78 While the reductions we observed in our model
did not reach statistical significance in the LBW/CD offspring, we did see a 15%
reduction in total protein levels, which we postulate would still have the ability to impair
complete lipid oxidation in these offspring. Reduced PGC-1α has also been observed in
C2C12 muscle cells exposed to hypoxia in culture, a key characteristic of adverse in utero
environments.79 The ability of hypoxia alone to modulate the regulation of mitochondrial
lipid metabolism highlights a potential role for hypoxia and potentially its association
with oxidative stress in an adverse in utero environment80,81 in promoting later life
persistent mitochondrial dysfunction.
The sirtuins (SIRTs) are another important family of transcription factors
involved in regulating mitochondrial biogenesis and oxidative function. SIRT1, which is
predominantly localized to the nucleus or cytosol, promotes deacetylation of target
proteins involved in lipid metabolism and energy balance, including PGC-1α and
PPARα.54,82 Reduced levels of SIRT1 protein have been observed in skeletal muscle of
type 2 diabetic patients,83 as well as rats consuming high fat diets.84 This reduction in
SIRT1 has also been associated with hyperacetylation of PGC-1α and PPARα, preventing
their ability to complex with one another to induce lipid oxidation.55 We have observed
similar reductions in SIRT1 protein levels in our WD-exposed offspring, highlighting
impaired regulation of lipid oxidation through the SIRT1-PGC-1α pathway.
Additionally, SIRT3 which is exclusively located in the mitochondria, catalyzes the
deacetylation of proteins involved in β-oxidation as well as the electron transport
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chain.56,85,86 In rodents exposed to high fat diets, muscle levels of SIRT3 protein are
significantly reduced,87 similar to the reduced SIRT3 total protein level we observed in
gastrocnemius of WD-fed offspring. Since SIRT3 knockouts have been associated with
hyperacetylation of SIRT3 target proteins,88 preventing their activation and promoting
mitochondrial dysfunction in addition to insulin resistance,89 we speculate that the
reduced SIRT3 levels observed in our model would be associated with reduced activation
of SIRT3 target proteins, preventing complete lipid oxidation.
While FOXO1 protein levels were decreased following postnatal consumption of
a WD, FOXO1 phosphorylation at Ser256 mediated by Akt 90 was significantly increased.
As such, while there are reduced levels of FOXO1, the increased phosphorylation could
suggest an increased level of exclusion of the available protein from the nucleus, thus
negatively impacting transcription of gluconeogenic and lipid metabolism gene targets.91
Additionally, the increased phosphorylation, possibly mediated by Akt, suggests that Akt
retains its ability to phosphorylate these sites on FOXO1 despite an observed reduction in
Ser473 phosphorylation level, suggesting a potential compensatory activation of
alternative phosphorylation sites on Akt aimed at maintaining its kinase activity.
In terms of the regulation of mitochondrial biogenesis and function, the main
effects on the protein expression of these transcription factors were largely attributable to
consumption of a postnatal WD, with a trend towards decreasing levels of PPARα and
PGC-1α in response to a LBW outcome. However, the alterations observed in the
enzymes involved in β-oxidation were exclusively observed in LBW offspring,
irrespective of postnatal diet.

As such, it is possible that the defects inducing

acylcarnitine accumulation in LBW offspring versus WD-exposed offspring occur at
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different levels of the oxidative process, namely β-oxidation in LBW offspring, and
downstream TCA cycle or oxidative phosphorylation in the WD-exposed offspring.
These differential mechanisms, when superimposed on one another in the LBW/WD
offspring would have the potential to impair the oxidative process to a greater extent,
promoting increased acylcarnitine accumulation, similar to the interactive effect we
observed in numerous acylcarnitine species. As such, postnatal consumption of a WD
following a LBW outcome may exacerbate mitochondrial dysfunction, promoting
increased accumulation of acylcarnitine intermediates.

3.4.5 A Model Linking Mitochondrial Dysfunction and Defective Insulin Signaling
Acylcarnitine accumulation secondary to mitochondrial dysfunction has been
shown to activate pro-inflammatory signaling pathways and induce a state of oxidative
stress,27 promoting insulin resistance. Therefore, we sought to use PCA in order to
identify a cluster of metabolites that may be implicated in skeletal muscle insulin
resistance pathogenesis.

The first cluster, composed of medium- and long-chain

acylcarnitine species, accounted for more than 40% of the variation of the model,
highlighting this cluster of metabolites as important players in the pathogenesis of
mitochondrial dysfunction.

Medium- and long-chain acylcarnitines are known to

accumulate secondary to incomplete lipid oxidation, therefore representing a key
manifestation of mitochondrial dysfunction.21,57,58 The exact mechanisms associated with
acylcarnitine accumulation remain poorly defined, however the observed reductions in
CPT1, KT, PPARα, PGC-1α, SIRT1 or SIRT3 in our model are likely candidates
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modulating mitochondrial lipid metabolism, mitochondrial dysfunction and acylcarnitine
accumulation. Additionally, a significant main effect of diet was observed for PC1,
highlighting postnatal diet as a key contributor to the accumulation of these metabolites.
The metabolites of PC1 were also significantly correlated with activation of JNK, as well
as with inhibitory serine phosphorylation of IRS-1.

Recent evidence suggests

accumulation of C-14 carnitine in particular is able to induce phosphorylation and
activation of JNK,27 highlighting a potential mechanism by which mitochondrial
dysfunction and altered insulin signaling may be linked. In our model generated by PCA,
accumulation of medium- and long-chain acylcarnitines is also associated with increased
activation of JNK, promoting inhibitory serine phosphorylation of IRS-1 and disrupted
insulin signaling.

Interestingly, acylcarnitine accumulation has been observed in

individuals with pre-diabetes who do not display overt reductions in insulin sensitivity,92
highlighting that our offspring may also be at a pre-diabetic stage since we are seeing
molecular disruptions in mitochondrial function and insulin signaling without whole body
alterations in insulin sensitivity.
With the knowledge that hypoxia associated with IUGR induces a state of
oxidative stress in the fetus,93-95 we speculate that it is this exposure to oxidative stress
that initiates the persistent molecular alterations in insulin signaling and mitochondrial
metabolism. Limited nutrient supply in utero has been associated with an alteration in
the redox state of metabolic tissues of the fetus, altering their metabolic function.96
Additionally, low oxygen availability has been associated with decreased function of the
electron transport chain in fetal mitochondria, generating reactive oxygen species (ROS)
that leads to persistent oxidative damage to the mitochondria.97-99 Mitochondrial
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dysfunction itself has also been associated with ROS production,96 perpetuating a state of
oxidative stress that has the potential to activate stress-induced kinases or induce posttranslational modifications to important mitochondrial transcription factors.
In summary, IUGR culminating in LBW predisposes the offspring to disrupted
insulin signaling and mitochondrial lipid metabolism in skeletal muscle. Additionally,
early exposure to a postnatal WD independently induces alterations in mitochondrial lipid
metabolism and insulin signaling; however, consumption of this diet following a LBW
outcome likely unmasks a LBW-induced metabolic dysfunction, increasing the
offspring’s risk of developing insulin resistance. Lastly, alterations in mitochondrial
function, as observed by acylcarnitine accumulation, occur early in disease progression,
without overt disruption of whole-body glucose tolerance, highlighting a pre-diabetic
situation in these offspring. Characterization of other modulators, such as the epigenetic
drivers, of disrupted mitochondrial metabolism that may underlie the persistent molecular
changes observed when exposed to an adverse in utero environment will be the subject of
future studies.
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4.1 Summary
The importance of the in utero environment in modulating growth trajectory and
influencing the propensity for development of age-related metabolic diseases is rapidly
gaining recognition among healthcare professionals and government agencies. Evidence
strongly suggests that infants displaying IUGR, culminating in a LBW, are at greater risk
for developing type 2 diabetes, cardiovascular disease and obesity.1-8 The Developmental
Origins of Health and Disease (DOHaD) hypothesis first put forth by Forsdahl, Barker,
and expanded upon by others, postulated that development of these chronic, noncommunicable, metabolic diseases are the result of a programming mechanism initiated
during critical periods of in utero development in order to promote fetal survival in poor
intrauterine conditions.5,9-12 Recent evidence has also suggested that secondary insults in
postnatal life, including the increasingly accessible “Western” diet, have the potential to
exacerbate an already dysfunctional system, further increasing the risk of developing agerelated metabolic diseases.1,13,14 Given the increasing prevalence of non-communicable
metabolic diseases, understanding the mechanisms underlying fetal programming of adult
disease along with the contribution of postnatal diet on the development of metabolic
disorders is of critical importance.

While some mechanisms have been postulated,

including epigenetic modifications, oxidative stress, and nuclear receptor signaling,15-17
further delineation of the persistent molecular alterations initiated in utero remain to be
elucidated.
We chose to focus on the developmental programming of skeletal muscle insulin
resistance as it relates to development of later life progression to type 2 diabetes and
MetS, since skeletal muscle is the primary location for insulin-stimulated glucose
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uptake18 and a major regulator of whole body energy homeostasis.19 Overall, the present
studies provide strong evidence for the role of the in utero environment in modulating
skeletal muscle lipid metabolism and insulin signaling as a precursor to the development
of insulin resistance.

Additionally, the work presented in this thesis, as well as

others,13,14,20,21 provide further support that a postnatal diet characterized by relative
nutrient excess has the potential to exacerbate an already dysfunctional system and alter
growth trajectory (Chapter 2) and metabolism (Chapter 3) of the offspring.
In the first study (Chapter 2), we sought to characterize the growth and metabolic
parameters of offspring born following an adverse in utero environment, characterized by
reduced oxygen and nutrient supply, as they grew into young adulthood. Furthermore,
we also sought to investigate the relative contribution of a consistent, early exposure to a
postnatal Western diet on the potential for an increased risk of developing features of
age-related metabolic diseases. The study presented evidence that the immediate postbirth growth trajectory of LBW offspring is altered following IUGR, displaying rapid
postnatal catch-up growth from weaning through to PND50. This pattern of growth is
classically replicated in animal and human IUGR studies, and is traditionally associated
with

augmenting

the

offspring’s

risk

for

developing

age-related

metabolic

diseases.4,15,22,23 Few, if any, studies are available that examine this growth pattern when
LBW offspring are exposed to a true WD early in life consisting of high fat and high
processed sugars.

Early exposure to a postnatal Western diet appeared to have a

differential effect on growth trajectory, stunting the accelerated catch-up growth postweaning that is traditionally associated with LBW. Additionally, these WD-fed offspring
exhibited a non-obese phenotype and in fact displayed a significantly reduced overall
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adiposity. While our offspring displayed maintenance of whole-body glucose tolerance
and a non-obese phenotype at this young age, previously published studies in our lab,24-26
as well as investigation of skeletal muscle lipid metabolism (Chapter 3) highlight that
metabolic disturbances are indeed present in these offspring and may be associated with a
pre-diabetic phenotype.
The second study (Chapter 3) postulated that adverse in utero conditions would
impair skeletal muscle mitochondrial function and lipid metabolism, promoting a state of
mitochondrial dysfunction, which negatively alters insulin signaling. While whole-body
glucose tolerance, as well as skeletal muscle glucose uptake, was maintained, we
observed skeletal muscle-specific molecular alterations in insulin signaling and lipid
metabolism.

Additionally, we observed hallmarks of mitochondrial dysfunction,

including an increased level of acylcarnitine intermediates, in WD-fed, as well as in
LBW/CD offspring.

Furthermore, early consumption of a postnatal WD by LBW

offspring from weaning appeared to unmask LBW-induced metabolic disruptions by
early adulthood by inducing further accumulation of acylcarnitines.

Molecular

alterations in skeletal muscle lipid metabolism and insulin signaling are frequently
observed early in the pathogenesis of insulin resistance.8,27 Changes in these two
molecular pathways, in conjunction with maintenance of glucose uptake and glucose
tolerance, highlights a pre-diabetic phenotype, an early step in disease progression, as
previously reported in humans.7,8,27,28
Taken together, these two studies provide strong evidence for the role of the in
utero environment in modulating growth and future disease risk. In both studies, early
introduction of a postnatal WD altered growth trajectory and metabolism, potentially

149

unmasking and exacerbating LBW-induced metabolic dysfunctions. While our offspring
outwardly appear healthy due to their non-obese, glucose tolerant phenotype, our studies
highlight disruptions in skeletal muscle lipid metabolism and insulin signaling associated
with a developing metabolically unhealthy phenotype (Table 4.1)

4.2 Speculations
An adverse in utero environment typically observed in situations of IUGR has
been associated with hypoxia, reducing the amount of oxygen reaching the developing
fetus.29,30 Fetal hypoxia has been observed to correlate with the incidence of later life
cardiovascular disease in high altitude Bolivian populations,31 and has been replicated in
rodent studies as well.32,33 Skeletal muscle levels of key intermediates of insulin
signaling, including Akt and GLUT4, are significantly reduced in adults exposed to
prenatal hypoxia,34,35 further highlighting hypoxia as a key modulator of later life disease
risk, possibly by promoting a state of oxidative stress.36 IUGR has been associated with
increased indices of oxidative stress in the fetus,37-39 while oxidative stress has been
postulated to underlie the programming of later life hypertension. Therefore, oxidative
stress in utero has recently been highlighted as a potential mechanism promoting later life
metabolic disease. One mechanism by which this may occur is an altered redox state in
fetal tissues in response to limited oxygen and nutrient availability. These low oxygen
levels have the potential to decrease activity of the electron transport chain, reducing
oxidative phosphorylation, and generating ROS that promote persistent oxidative damage
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and mitochondrial dysfunction.27,40,41 Additionally, mitochondrial dysfunction itself leads
to production of ROS, further perpetuating a state of oxidative stress.17
Of note, progression of insulin resistance following consumption of a WD is also
strongly associated with a state of oxidative stress.42-44 Mitochondrial dysfunction is also
known to occur secondary to high-fat feeding,43,45,46 increasing mitochondrial stress and
decreasing mitochondrial oxidative phosphorylation.47 This impairment in mitochondrial
function promotes ROS generation, as well as acylcarnitine accumulation, both of which
have the potential to activate stress-induced kinases that mediate alterations in insulin
signaling.48-51

Of note, the molecular disruptions occurring in skeletal muscle of

LBW/CD offspring and NBW/WD offspring, and their associated phenotype, are similar
among these two groups. This suggests that a similar trigger may be responsible for
inducing the metabolic dysfunctions in both these groups, namely oxidative stress.
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Growth & Feeding Behaviour
AGR
Food Intake
Calorie Consumption
Feed Efficiency
Body Composition
Whole-body Adiposity
Mesenteric Fat Pad Mass
Glucose Homeostasis
Whole-body Glucose Tolerance
Skeletal Muscle Glucose Uptake
GLUT4
GLUT2
GLUT5
Fatty Acid Uptake
CD36
FATP1
FATP4
Mitochondrial Oxidation
CPT1 (mRNA & protein)
VLCAD
MCAD
PDK4
KT
PGC-1α (protein)
PPARα (protein)
Mitochondrial Biogenesis
SIRT1
SIRT3
FOXO1
pFOXO1
Mitochondrial Dysfunction
Acylcarnitines
Stress-Induced Kinases
pJNK
pIKKβ
PKC-θ
Insulin Signaling
pIRβ
pIRS-1
p85
p110
pAkt (Ser473)
pAkt (Thr308)
pAS160
Skeletal Muscle Lipid Profile
Triglycerides
Diacylglycerol
Cholesterol
Saturated Fatty Acids
Omega 6/Omega 3 Poly-unsaturated
Fatty Acids

Birth Weight

Diet

ê

ê

ê

é
ê

Birth Weight/Diet
Interaction

ê
ê

é
é

ê
é

é
ê

ê
é

éé

ê

ê
ê p=0.0797
êp=0.0845

ê
ê

é

ê
ê
ê
é

é

é

éé

é
é

é

é
é

é
ê
êp=0.0977
êp=0.0590

ê
é

ê

êêp=0.0803
é

é
ê
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Table 4.1: Summary Table of Birth Weight and Diet Effects and Their Interaction
on Postnatal Growth, Skeletal Muscle Lipid Metabolism and Insulin Signaling.

4.3 Potential Limitations
Unfortunately, no study is perfect and there are limitations that must be addressed.
Firstly, in both studies presented, we chose to examine only male offspring in order to
reduce confounding variables associated with estrus cycle and differences in hormonal
profiles between females and males. Previous studies have highlighted an increased
susceptibility of males to the programming effects of an adverse in utero
environment,52,53 further prompting us to limit the current studies to male offspring at this
time. However, studies that have examined both males and females have highlighted
differential responses between the sexes to the influence of the in utero environment on
later life insulin sensitivity.54,55 For example, IUGR offspring in animal models are
known to display improved insulin sensitivity in very early postnatal life; however, a shift
towards impaired glucose clearance and decreased insulin sensitivity was observed as
these offspring aged.52,56,57 Interestingly, the timing of this shift in insulin sensitivity
appears to be sex-specific, with insulin action being impaired earlier in males in
comparison to females.52,55 Therefore, investigation of our female cohort would have
provided insight into the mechanisms associated with fetal programming of insulin
resistance and how each sex responds to the initial in utero insult.
Secondly, our assessment of insulin resistance may have been improved overall.
While we were able to extensively profile the expression and phosphorylation of the
insulin signaling cascade in the skeletal muscle, we were unable to assess insulin
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sensitivity at the whole-body level or skeletal muscle level directly. Unfortunately, due to
the low sequence homology between human and guinea pig insulin,58 assessing insulin
levels in vivo in the guinea pig is challenging. We have currently been unable to generate
confident results for plasma levels of insulin with commercially available ELISAs,
despite numerous attempts, therefore limiting our ability to report in vivo insulin levels
and to generate indices of whole-body insulin resistance. We have attempted to perform
whole-body insulin tolerance tests (ITT) using an intraperitoneal injection of 1IU/kg of
human insulin, as determined by a dose-response study. To assess insulin sensitivity we
measured the percent drop in blood glucose values over the course of the 22-minute ITT,
as a reflection of the ability of insulin to reduce blood glucose levels.59 However, due to
a small sample size and inconsistent results, we do not feel confident reporting on the
whole-body insulin sensitivity of our cohort at this time. Going forward, further refining
our insulin tolerance test protocol and continuing to optimize the measurement of plasma
insulin levels in the guinea pig would be important in order to confidently speak to the
overall insulin sensitivity of our cohort.
Additionally, all in vivo measurements were performed in the basal, fasted state,
as were the final tissue collections. While we were able to observe significant alterations
in skeletal muscle lipid metabolism and insulin signaling in the basal state in agreement
with other studies,8,60 observations in the insulin-stimulated state would have
strengthened our conclusions. It would have been beneficial to observe if the skeletal
muscle was able to mount a response to exogenous insulin since insulin resistance is
typically characterized by a reduction in glucose uptake in response to insulin
stimulation.61 To address this, performing the

18

F-FDG PET scans following insulin

154

administration would allow us to determine if skeletal muscle was able to take up glucose
in response to insulin. As reported by Reichkendler et al, exercise training was observed
to increase insulin-stimulated glucose uptake in skeletal muscle, highlighting FDG-PET
scans as a useful technique to assess in vivo skeletal glucose uptake in response to insulin
administration.62 Also, performing our tissue collections immediately following insulin
injection would have allowed us to compare the phosphorylation state of key insulin
signaling intermediates in the basal and insulin-stimulated state in order to investigate
their activation in response to insulin, and whether insulin-stimulated phosphorylation of
key signaling intermediates was blunted.
The fasted-to-fed transition is also important in highlighting metabolic
disruptions.63,64 Studies have shown that during the metabolic transition from a fasted to
fed state, diabetic individuals fail to shift from fatty acid to glucose oxidation, depleting
TCA cycle intermediates and highlighting a metabolic inflexibility.65 Therefore,
examining some animals in the fed state would allow for a metabolic comparison that
may highlight the development of metabolic inflexibility associated with MetS disease
progression. Additionally, mitochondria in skeletal muscle are thought to be particularly
vulnerable to the nutritional milieu, with the mitochondria of obese animals displaying
inabilities to adjust fatty acid influx in response to nutritional status, which is particularly
evident in the fed state.63 It has also been suggested that metabolic inflexibility in
response to nutrient status occurs early in disease progression,63,64 highlighting early
detectable markers that may be used to monitor disease progression. Although the fasted
state allowed us to assess basal metabolic parameters, it would be beneficial to observe
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how these metabolic parameters are altered in the non-fasted state and whether the fastedto-fed transition highlighted any further impairment in skeletal muscle lipid metabolism.
Finally, considerations must be made when analyzing our protein expression data
of the transcription factors involved in regulating mitochondrial β-oxidation, as
reductions in protein levels do not always imply reductions in activity. Activity of these
transcription factors is tightly regulated by post-translational modifications that facilitate
or inhibit the ability of these proteins to activate their target genes. For example, the
acetylation status of both PPARα and PGC-1α are known to impact their ability to
complex with one another to induce their gene targets. SIRT1 is an important component
of this regulation, responsible for deacetylating PGC-1α, allowing it to complex with
PPARα to promote lipid oxidation.66 However, when SIRT1 is not active, PGC-1α
remains hyperacetylated, preventing upregulation of lipid oxidation.67 Therefore,
investigation into the activity and post-translational modification of these transcription
factors involved in mitochondrial biogenesis and oxidative function may provide insight
into the mechanisms by which mitochondrial lipid metabolism is regulated and how an
adverse in utero environment may induce persistent alterations to these transcription
factors.

4.4 Future Directions
As mentioned above, the current studies were limited to male offspring; therefore,
further investigation of the programming events underlying insulin resistance in female
offspring would be of great value. Preliminary evidence suggests that females are,
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similar to the males, glucose tolerant at this young age; however, molecular investigation
of skeletal muscle insulin signaling and mitochondrial lipid metabolism remains to be
completed.

Investigation of the same markers in the females would allow for

determination of sexually dimorphic effects of the in utero environment on the
development of insulin resistance.
Furthermore, it would be worthwhile to conduct another longitudinal study to
examine later time points in order to determine if the glucose intolerant phenotype would
emerge in the cohort as they aged. Our current time point for sacrifice, approximately
PND145, is still within the young adult period for the guinea pig.68,69 Many noncommunicable, metabolic diseases do not present until the effects of aging and insults in
later life are compounded with insults that occurred in early life.1,9 Therefore, due to the
young age of our animals, it is possible that overt symptoms of MetS have not yet had
time to manifest. Guinea pigs subjected to a high fat diet for 7 months are known to
display mild glucose intolerance,70 highlighting that with continued exposure to a
postnatal WD, overt manifestations of MetS are likely to occur. Given the proper funding
and resources, a longitudinal study that follows the cohort through to 7-8 months of age,
or until observable manifestations of MetS are present, would be of great interest.
Additionally, it would be of interest to determine which component, excess fat or
excess sugar, of the postnatal WD had the largest contribution to the diet effects we
observed. This could be accomplished by designing diets isocaloric to our WD, with one
diet containing excess fats alone and one diet containing excess sugars alone.

By

introducing these diets to a subset of our cohort from weaning, performing the in vivo
measurements and molecular analysis, in comparison to a control diet and a Western diet,
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we would be able to determine whether it is the excess fat or the excess sugar present in
the WD that is generating the effects we observed in these studies. We speculate that the
excess fats present in a high fat diet would promote defects in skeletal muscle lipid
metabolism,63,71 whereas excess sugars would have the potential to alter body
composition and glucose tolerance.72-74
As previously mentioned, the reduced protein expression of the transcription
factors regulating mitochondrial biogenesis and oxidative function needs to be explored
further. Investigation of post-translational modifications, including phosphorylation and
acetylation, that are known to modulate the transcriptional activity of these transcription
factors is required in order to associate these changes in protein expression with
alterations in function. PGC-1α phosphorylation can be mediated by 5’ adenosine
monophosphate-activated protein kinase (AMPK) at Thr177 and Ser538,75 and is known to
promote PGC-1α stability, allowing activation of gene targets;66 whereas Akt-mediated
phosphorylation of PGC-1α at Ser570 inhibits transcriptional activity.76 Therefore,
investigation of PGC-1α phosphorylation may provide insight into the activation of this
transcription factor. Acetylation of lysine residues of the transcription factors regulating
mitochondrial metabolism has also recently been highlighted as an important control
mechanism regulating the ability of these transcription factors to form the complexes
required to initiate transcription of their gene targets.77 The acetylation status of PGC-1α
and PPARα are tightly regulated by SIRT1, a deacetylase activated in response to
nutrient availability.66 Upon activation, SIRT1 catalyzes the reversible deacetylation of
PGC-1α and PPARα, allowing them to complex together in order to induce transcription
of their gene targets.78,79 Therefore, assessing the acetylation status of PGC-1α and
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PPARα may provide insight into the activity of SIRT1 as well as the regulation of
oxidative gene targets. Additionally, chromatin immunoprecipitation could be employed
to investigate the binding of these transcription factors to their target promoters,
providing further information regarding how these transcription factors may be inducing
the observed reductions in mitochondrial β-oxidation.
While the phosphorylation of FOXO1 was maintained, in conjunction with a
reduced Akt phosphorylation level, investigation regarding mechanisms by which this
phenomenon may occur would be of value given Akt does play a major role in regulating
FOXO1phosphorylation status. In situations of insulin resistance, phosphorylation of
FOXO1 is often reduced, resulting in hyperactivation of FOXO1 and disruption of
glucose homeostasis.45 Since we observed enhanced phosphorylation of FOXO1 at Ser256
following

postnatal

WD-consumption,

investigation

of

alternative

sites

of

phosphorylation, namely Thr24 and Ser319, which is mediated by other kinases such as
serine/threonine kinase SGK

80

would allow for a better understanding of FOXO1

transcriptional regulation of glucose and lipid homeostasis in states of altered insulin
sensitivity.
Additionally, it would be of value to assess the regulation of PI3-kinase and its
ability to activate Akt. The PI3-kinase signaling pathway is incredibly important in
regulating not only glucose homeostasis, but also protein synthesis, proliferation,
differentiation and cell survival depending on which downstream targets of Akt are
activated.81

One critical phosphatase that catalyzes the dephosphorylation and

deactivation of PI3-kinase is phosphatase and tensin homologue deleted on chromosome
10 (PTEN).81 An increase in the gene expression and protein levels of PTEN have been
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observed in rodent models of type 2 diabetes,82 suggesting PTEN as an important player
in insulin resistance pathogenesis. Dephosphorylation of PTEN at Ser380, Thr382, and
Thr383 promotes PTEN activity,83 and PTEN activity has been observed to increase in
response to excess free fatty acid availability.84 Therefore, assessing the phosphorylation
and activation of PTEN may provide insight into the regulation of PI3-kinase in response
to insulin stimulation, and its ability to facilitate glucose uptake through the Akt/AS160
branch of this signaling pathway.
Lastly, other post-translational and epigenetic mechanisms need to be further
explored in order to explain the long-lasting effect of adverse in utero growth on later life
skeletal muscle function and metabolism. Epigenetic alterations initiated in utero are
hypothesized to occur in response to adverse environments, which may ultimately
promote survival in the short term but may have long-term detrimental effects on
metabolic pathways.15,85,86 Research aimed at determining a molecular mechanism
linking environmental cues to altered persistent gene expression and later life disease
progression has highlighted DNA methylation as a likely candidate.66 Hypermethylation
of the PGC-1α promoter region has been associated with reduced gene expression in
LBW offspring,87,88 as well as diabetic subjects,89 preventing PGC-1α expression and
impairing mitochondrial oxidative function. Additionally, hypermethylation has been
observed in response to hypoxia,90 highlighting another mechanism by which adverse in
utero environments may induce permanent epigenetic alterations to metabolic function.
Small non-coding RNAs known as microRNAs (miRNA) have also been gaining
recognition for their role in disease pathogenesis.85 Given mRNA was not changed for the
transcription factors we investigated but protein levels were decreased, miRNAs are
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potential candidates mediating this phenomenon as they initiate post-transcriptional
regulation of protein expression.91

miRNA-34a has recently been observed to be

associated with a decrease in SIRT1 translation in vitro,79 whereas miRNA-15b and
miRNA-16 have been associated with alterations in insulin signaling proteins in response
to diabetes and LBW.92 Oxidative stress has also been observed to be an integral
component in not only aging, but also age-related metabolic disease progression, by
promoting epigenetic alterations in metabolism through miRNAs.93 As such, future work
investigating the epigenetic mechanisms underlying the persistent molecular alterations
in skeletal muscle metabolism observed following an adverse in utero environment and
the interaction with the postnatal environment is required.

4.5 Conclusions
The results of the present study provide further evidence for the importance of the
in utero environment in modulating later-life disease risk. We also highlight that while
young LBW offspring may outwardly appear healthy due to a non-obese, glucose tolerant
phenotype, subtle changes at the level of the skeletal muscle represent a developing
metabolically unhealthy phenotype. These persistent molecular alterations to the insulin
signaling pathway and mitochondrial lipid metabolism following consumption of a
postnatal WD or an adverse in utero environment are early markers of insulin resistance
pathogenesis, increasing the risk of these offspring for developing insulin resistance and
the components of MetS. Additionally, consumption of a postnatal WD following a
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LBW outcome appears to exacerbate the metabolic disturbances initiated in utero, putting
these offspring at greater risk for developing insulin resistance and other aspects of MetS.
Studies from other groups, as well as colleagues in our laboratory, have
highlighted that other physiological parameters, including vascular and adipose
development, of LBW offspring is unique in comparison to NBW offspring.13,14,24-26 The
mechanisms underlying metabolic disease in the LBW offspring in comparison to that
induced by poor diet in adulthood may be different. In this study, an adverse in utero
environment modulated a different set of enzymes and transcription factors regulating
mitochondrial lipid oxidation than consumption of a postnatal WD.

However, the

divergent pathways converge upon similar stress-induced kinases and each induced
alterations in the insulin signaling pathway, leading to a similar overall phenotype.
Activation of these multiple pathways, when superimposed upon each other due to
consumption of a poor postnatal diet following IUGR, may have the potential to further
increase disease risk.
Of particular concern are recent studies highlighting that LBW offspring are
unable to lose weight as efficiently as normal birth weight offspring when they are placed
on a calorie restricted diet,94 and that IUGR-induced deficiencies in PGC-1α appear
resistant to exercise interventions targeted to improve symptoms associated with MetS.95
These LBW offspring with a unique metabolic profile, while being at higher risk of
developing components of MetS, may be resistant, or lack the plasticity to respond to
current intervention practices, highlighting the need for LBW-specific therapeutic
options. Additionally, current intervention strategies to combat metabolic disease are
mostly targeted to overweight or obese individuals.96,97 However, as observed in these
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studies, as well as others,72,74,98 these young LBW offspring are non-obese, highlighting
the need for further investigation into therapeutic options that are not centered around
obesity and its contribution to MetS pathogenesis. Therefore, it is imperative that further
investigation into not only the molecular mechanisms underlying the developmental
programming of metabolic disease be conducted, but also investigation into how we can
translate this knowledge into LBW-specific therapeutic options designed for the unique
metabolic profile associated with adverse growth in utero.
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Acylcarnitine Short Hand
C2
C3
C4
C5
C6
C8
C10
C12
C14
C16
C18
C14:1
C16:1
C18:1
C18:2
C18:3
C20:4
C22:5
C4-OH
C12-OH
C14-OH
C16-OH
C18-OH
C18:1-OH

Common Name
Acetyl Carnitine
Propionyl Carnitine
Isobutyryl Caritine
Isovaleryl Carnitine
Hexanoyl Carnitine
Octanoyl Carnitine
Decanoyl Carnitine
Lauroyl Carnitine
Myristoyl Carnitine
Palmitoyl Carnitine
Stearoyl Carnitine
Tetradecenoyl Carnitine
Palmitoleoyl Carnitine
Oleyl Carnitine
Linoleoyl Carnitine
Octadecatrienoyl Carnitine
Arachiodonoyl Carnitine
Docosapentaenoyl Carnitine
3-Hydroxy-Butyryl Carnitine
3-Hydroxy-Dodecanoyl Carnitine
3-Hydroxy-Tetradecanoyl Carnitine
3-Hydroxy-Hexadecanoyl Carnitine
3-Hydroxy-Octadecanoyl Carnitine
3-Hydroxy-Octadecenoyl Carnitine

Appendix Table 1.1: Acylcarnitine Profile Short Hands.
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